ML20078R707
| ML20078R707 | |
| Person / Time | |
|---|---|
| Site: | Fort Saint Vrain  |
| Issue date: | 10/31/1983 |
| From: | Borst F PUBLIC SERVICE CO. OF COLORADO |
| To: | |
| Shared Package | |
| ML20078R693 | List: |
| References | |
| RPAP-2, NUDOCS 8311150262 | |
| Download: ML20078R707 (55) | |
Text
'
i W1.!G U.:i, , iGi: Li.....'ll'( UF C ' z i a , . i ; >. L O m A,' - 2 i r c:4 r sr. v m- et sa crf. ' A r t e, c, r A m N I500 1 j' h ;e 1 of 23 O
TITLE: 01rSITE C05E CALCulATIC'i MANUAL ISSUANCE AU TilORl/LD s 2 ny ['lf)' .b6lS[-
IC;iC .5 4 0 DCT 2 0 Mu (("_-_":o3,_33_
1.0 PURPOSE This Offsite %se Calculaticnal am l
("U) provides he information I r.d 3Dr Jologies to be used by Fort St. Vrain (fSV) to ass ure ccrsplic ace with FSV's Technical Speci fica ticas rela trd to liquid and ga<,cus radiological effluents. Th 3y are intrmied to show c o:..p l i a nc e with 10 CFR 20, 10 ClR 50.361, 10 CiR 50, Apper. dix A (GDC 60 & 64) and ?.ppcodix I, and 40 CFR '90.
This ODCM is based on " Radiological Effluent Tede N u Specifications for 3.R's (NUREC-0472, Draft)," "Preparatien af Radiological Ef flu. nt Technical Specifications for Nuclear Pm.'ar Plint s (';URFG-0!33)," and other inputs from the "aclear P gulatory Cc lission (USNRC). Specific plar;t p oc~' .res for inplcmentition af this manual are prcvided el w.here. Th-se p i m: dures will be utilized by the operating staff of !SV to assure compli.nce with the Technical Specifications.
Also included in this manual is information related to the Radiological Environmental Monitoring Program (REMP) in AliACH.
RPAP-2F. This attachment designates specific sample types and locations currently used to satisfy the Technical Specification requirements for the REMP. They are subject to change based on the results of the periodic land use census.
This ODCM has Y en pr,> pared as generically as pos,ible in ordar to nininize the rnod for future rr. visions. Ros.e cN.rges t o the Ori.M will be r' 'ed in the fr ure. .' ny s u :h d c.n.3 e s w i l l Le p rge rly rav .cd -d o ^ppet <c d as in % rd in 'i e Administrative r:rtrol etion of the iSV G<' ical -
Specifirations.
2.0 AFPlir a. IL1iy.
- ~
l . ,
"
- b
. I g u < , s e f f l .' i it r d ms S , fr- sit to ' '; e FSV F- H W 1 S;. i. i iit iti, a; 8311150262 831031 PDR ADOCK 05000267 P PDR
, , u
.; PUBLIC SERVICE COMPANY OF COLORADO RPAP-2 FORT ST. VR A,1N NUCLEAR GENER ATING STATION sue 1 3.0 GENERAL The Radiation Protection Manager (RPM) shall be responsible to assure that the ODCM is utilized in accordance with the FSV Technical Specifications. The RPM is also responsible for ensuring that all radioactive waste is handled, stored, and disposed of in accordance with NP.C Requirements and FSV procedures.
NOTE: If the calculated alarm setpoint for any of the FSV radiation monitors exceeds the range of the instrument, appropriate lower setpoints will be determined by the RPM.
In all cases since the setpoint is reduced, compliance with the limits in this procedure will be assured.
4.0 PROCEDURE 4.1 LIQUID EFFLUENTS 4.1.1 Monitor Alarm Setooint Determination Monitor alarm setpoints will be determined in order to assure compliance with 10CFR20. The setpoints will indicate if the concentration of radionuclides in the liquid effluent at the site boundary exceeds the concentrations specified in 10CFR20, Appendix B, Table II, Column 2 for radionuclides other than dissolved or entrained noble gases. The setpoints will also assure that a concentration of 2 x 10
- pCi/ml for dissolved or entrained noble gases is not exceeded.
i l
l l
FORM 37; 22 3643
PUBLIC SERVICE COMPANY OF COLCil ADO RPAP-2 FORT ST. VRAIN NUCLEAR GENERATING STATION lssue)
Page a of 23 4
a) Liquid Waste Activity Monitors (RT 6212, RT 6213)
Monitor alarm setpoints will be calculated prior to each batch release from the liquid waste monitor tank or receivers. Prior to release, the contents of the tank to be released shall be passed through redundant liquid waste activity monitors, and the monitors' response documented. The monitor response (CPM) will be correlated with gamma spectral analysis obtained from an NBS traceable laboratory computer system (pCi/cc) to arrive at a monitor sensitivity, expressed in pCi/cc/ CPM, for each release. Data from this correlation will be compiled and evaluated to determine if monitor response can be predicted when varying quantities of mixed-gamma radionuclides are present. These monitors are responsive to all gamma-emitting radionuclides with energies between 70 kev and 2000 kev (approximate) which encompasses most fission and activation products which are likely to be encountered in HTGR liquid effluent. Having obtained an observed count rate above background for the liquid to be released, the monitor alarm setpoint will be set at 25% above the observed count rate to avoid spurious trips. In all cases, it will be determined prior to release that this 25%
increase will not result in exceeding the MPC of the unrestricted area.
For continuous releases from the Reactor Building Sump, the liquid waste activity monitor setpoints will be determined based on an NBS traceable 282I isotopic calibration of the monitors. Based on the sensitivity of the l
monitor (uci/cc/ cpm), a monitor response (cpm) corresponding to the unrestricted area MPC for unidentified radionuclides will be determined.
The alarm setpoint for continuous Reactor Building Sump releases will be obtained by reducing the above response by a factor of 2.
This is done in the interest of ALARA.
l l
FORM 372 36E3
PUBLIC SERVICE COMPANY OF COLORADO RPAP-2 FORT ST. VRAIN NUCLEAR GCNERATING STATION of 23 s
b) Multiple Release Points All liquid waste from FSV is discharged via a common line. FSV Technical Specifications prohibit simultaneous releases from the Liquid Waste System and the reactor building sump.
All releases are monitored by the Liquid Waste Activity monitors. There are therefore no multiple release points and monitor settings do not have to be reduced to account for multiple releases.
4.1.2 Compliance With 10 CFR 20 In order to show compliance with 10 CFR 20, the concentrations of radioriuclides in liquid effluents will be determined and compared with maximum permissable concentrations (MPC) as defined in Appendix B, Table II of 10 CFR 20 (Reference 5.2).
Concentrations of radioactivity in effluents prior to dilution will be determined. Concentration in diluted effluent will be calculated using these results prior to each batch release, and following .
each batch release.
FORM 372 22 3643
y PUBLIC SERVICE COMPANY OF COLORADO R N -2 S
- FORT ST. VRAIN NUCLEAR GENERATING STATION 5 of 23 a) Batch Releases
- 1. Prerelease The radioactivity content of each batch release will be determined prior to release. FSV will show compliance with 10 CTR 20 in the following manaer:
The concentration of the various radionuclides in the batch release prior to dilution, is divided by the minimum dilution flow to obtain the concentration at the unrestricted area. This calculation is shown in the following equation:
R X Conc $ = C3 (4.5)
MDF where:
Conc $
= Concentration of radionuclide i at the unrestricted area, pCi/ml; C
4
= Concentration of radionuclide i in the potential batch release, pCi/ml, R = Release rate of the batch, gpm; X = 1.25 to account for the monitor setpoint increase of 25% when determining that Conc $ will not exceed MPC $
l limits.
= 1.0 when determining compliance to 10CFR20 MPC limits for the concentrations measured in the batch release.
MDF = Minimum dilution flow, gpm.
FORM 372 22 364
. PUBLIC SERVICE COMPANY OF COLORADO RPAP-2 FORT ST. VRAIN NUCLEAR GENERATING STATION fssue 6 of 23 s
The projected concentration in the unrestricted area is compared to the concentrations in Appendix B, Table II of 10 CFR 20, (Reference 5.2). Before a release may occur, equation 4.6 must be met for all isotopes. For FSV the MDF is 1,100 gpm. The maximum release rate is 10 gpm.
l- Conc $ -l I l l s 1 (4.6) i l MPC l
l- -l where MPC = Maximum permissible concentration of radionuclide i from REFERENCE 5.2, pCi/ml.
O FORM 372 22 - 364
PUBLIC SERVICE COMPANY OF COLORADO RPAP-2 FORT ST. VRAIN NUCLEAR GENERATING STATM)N Issue.1 ,
Page ,/ o,. 20 4
4.1.3 Liouid Effluent Doses - Compliance with 10 CFR 50 Doses resulting from liquid effluents will be calculated monthly to show compliance with 10 CFR
- 50. A cumulative summation of total body and organ doses for each calendar quarter and calendar year will be maintained as well as projected doses for the next month, a) Determination of Liquid Effluent Dilution To determine doses from liquid effluents the near field average dilution factor for the period of release must be calculated. This dilr. tion factor must be calculated for- each batch release. The dilution factor Fk is determined by:
R k
Fk* (4'7)
X ADF k
where:
R = Release rate of the batch during k
time period k, gpm; ADF = Actual dilution flow during the time k
period of release k, gpm.
The value of X is the site specific value for the mixing effect of the FSV discharge structure. This value is 1 0 for FSV.
w FORM 372 - 22 36MB
PUBLIC SERVICE COMPANY OF COLORADO RPAP-2 FORT ST. VRAIN NUCLEAR GENERATING STATION e 8 of 23 b) Dose Calculations The dose contribution from the release of liquid effluents will be calculated monthly.
The dose contribution will be calculated using the following equation:
D = IIA $
t k ik Fk (4*b) ki where:
D = The dose commitment to the total body or any organ, from the liquid effluents for the 31 day period, mrem; C = The average concentration of ik radionuclide, i, in undiluted liquid effluent for the release k, pCi/ml; Ag = The site related ingestion dose commitment factor to the total body or any organ t for each identified principal gamma and beta emitter, mrem /hr per pCi/ml; F = The near field average dilution k
factor for C ik during liquid efflut release k, as defined in Section *.1.3 a) t = The length of time for release k, k
hours l
FORM 372 - 22 364
PUBLIC SERVICE COMPANY OF COLORADO RPAP-2 S '
FORT ST. VRAIN NUCLEAR GENERATING STATION 9 f 23 The dose factor A h was calculated for an adult for each isotope using the following equation:
Ah = 1.14 x 105 (21BF$ ) DF 9 (4.9) whero 1.14 x 105 = 10' pCi x 10' ml x 1 yr; yCi T 8760 hr 21 = Adult fish consumption, kg/yr; BF = Bioaccumulation factor for 3
radionuclide i in fish from Table A-1 of Regulatory Guide 1.109 Rev. 1, pCi/Kg per pCi/1; (REFERENCE 5.3)
DF = Dose conversion factor for h
radionuclide i for adults for particular organ t from Table E-11 of REFERENCE 5.3, mrem /pC1.
A values for an adult at FSV are present in h
ATTACH. RPAP-2A. The potable water pathway does not exist at FSV. Therefore, the potable water term was excluded from the calculation of A h values.
c) Cumulation of Doses Doses calculated monthly will be summed for comparison with quarterly and annual limits.
The monthly results should be a_dded to the doses cumulated from the other months in the quarter of interest and in the year of
~
interest. The following relationships should hold:
For the quarter, Dose < 1.5 mrem total body Dose < 5 mrem any organ For the Calendar year,
'~
Dose < 3 mrem total body Dose < 10 mrem any organ FORM 372 22 - 3643
PUBLIC SERVICE COMPANY OF COLORADO RPAP-2 e
FORT ST. VRAIN NUCLEAR GENERATING STATION The quarterly limits given above represent one half of the annual design objective. If these quarterly or anrual limits are exceeded, a special report should be submitted stating the reason and corrective action to be taken. If twice these limits are exceeded, a special report will be submitted showing compliance with 40 CFR 190.
4.2 GASEOUS EFFLUENTS 4.2.1 Monitor Alarm Setooint Determination Monitor alarm setpoints will be determined in order to assure compliance with 10CFR20. The setpoints will indicate if the dose rate at or beyond the site boundary due to noble gas radionuclides in the gaseous effluent released from the site exceeds 500 mrem / year to the whole body or exceeds 3000 mrem / year to the skin.
a) Reactor Building Exhaust Stack Noble Gas Monitors (RT 7324-1, RT 7324-2, RT 4803)
The following method applies to gaseous releases via the Reactor Building Exhaust Stack when determining the alarm setpoint for the Reactor Building Exhaust Stack Noble Gas Monitors which initiate isolation of Reactor Building releases.
FORM 372 22 364
PUBLIC SERVICE COMPANY OF COLORADO RPAP-2 FORT ST. VRAIN NUCLEAR GENERATING STATION Issue.1 Page 11 of 2:
- 1) Batch Releases The monitors will be calibrated using an NBS traceable '5Kr gas stream. Utilizing this method, the sensitivity (uci/cc/ cpm) of the monitors will be established.
These monitors utilize beta-scintillators which are responsive to all beta energies greater,than 100 kev (approximate). This encompasses most noble gases which are likely to be encountered in HTGR effluent. Most noble gases decay by beta emission and therefore should yield a similar response on these monitors proportional to the activity present in the effluent stream. This will be confirmed by correlation of monitor response with gamma spectral analysis obtained from an NBS traceable laboratory computer system using gas samples taken from the gas waste hold up system prior to release. The expected count rate (cpm) for the monitors from a batch gas waste release will be determined based on the isotopic analysis of the tank to be released (uci/cc) and the monitor sensitivity (uci/cc/ cpm). Having obtained the expected count rate above background for the gas to be released, the monitor alarm set point will be set at 25% above the expected count rate to avoid spurious trips. In all cases it will be determined prior to release that this 25% increase will not result in exceeding the MPC at the unrestricted area.
9 m
FORM 372 22 364
PUBLIC SERVICE COMPANY OF COLORADO RPAP-2 ssue FORT ST. VRAIN NUCLEAR GENERATING STATION o 23-The allowable rate, r, is calculated as follows:
I $rC $X s 3 X 10"cm' sec (MPC)$
where:
C4 = concentration in pCi/std.cc of radioisotope i; MPC4 = maximum permissible concentration of radioisotope i, per 10CFR20, in pCi/cm ; 8 r = release rate in std.cc/sec; and x = 1.0 when determining compliance to 10CFR20 limits for the concentrations measured in the batch release and
= 1.25 to account for the monitor setpoint increase of 25% when determining that C$w ill not exceed MPC 4 limits.
- 2) Continuous Releases The monitor setpoints for both the stack and gas waste header (RT-6314-2) noble gas monitors will be established per
. Sections 11.1.1.3 and 11.1.2.3 and Table 11.1-5 of the FSV FSAR to ensure that an annual whole body dose of 500 mrem is not exceeded at the Exclusion Area Boundary
( EAB) .
Exhaust stack flow rate is assumed to be 38,000 ft'.
min For the stack noble gas monitors, the setpoint is calculated as follows:
Setpoint (CPM) = 3.12E+4 uCi (Table 11.1-5) sec 3.6E+7 cc/sec X monitor sensitivity uC1/cc CPM where: 3.6E+7 = 38.000 ft'/ min X 28314 cc/ft' X 2 (ALARA) 60 sec min FORM 372 22 - 360
PUBLIC SERVICE COMPANY OF COLORADO RPAP-2 FORT ST. VRAIN NUCLEAR GENERATING STATION of 23 For the gas waste header noble gas monitor, the setpoint is calculated as follows:
Setpoint (CPM) = 5.2E-luCi/cc (11.1.2.3) monitor sensitivity uCi/cc x 2 ( ALARA)
- b. Reactor Building Exhaust Stack Iodine and Particulate Monitors Setpoints for the exhaust stack Iodine monitors RT-7325-1, RT 73437-1, RT-4802) will be determined utilizing the methodology of Sections 11.1.1.3 and 11.2.3.1.2.1.5 of the FSV FSAR and an additional reduction of two for ALARA purposes.
This setpoint utilizes MPC/700 for l'2I(milk cycle considerations).
Setpoint (CPM) = 7.4E-9pCi/cc (11.1.1.3) X 432 min instrument sensitivity uC1/cc CPM / min where: 432 = .6d X 24 hr X 60 min d hr 2 ( ALARA)
Setpoints for the gas waste header Idodine monitor (RT-6314-1) is determined utilizing the methodology of Sections 11.1.1.3 and 11.1.2.3 of the FSV FSAR and an additional reduction of two (ALARA).
Setpoint (CPM) = 3.2E-5 uCi/cc (11.1.2.3) X 432 min instrument sensitivity uCi/cc CPM / min Setpoints for the exhaust stack particulate monitors (RT-73437-2, l
RT-4801) will be determined utilizing the methodology of Sections 11.1.1.3 and Table 11.1-7 for 90 Sr and an additional reduction of 2 (ALARA).
FORM 372 - 22 364
c PUBLIC SERVICE COMPANY OF COLORADO iiPAY-2 FORT ST. VRAIN NUCLEAR GENERATING STATION l of 23 l
l 1
l Setpoin (CPM) = 2.6E+2 uCi/sec (Table 11.1-7) X 432 min instrument sensitivity uCi/cc X 1.8E+7 cc/sec CPM / min where: 1.8E+7 = 38,000 ft'/ min X 28314 cc/ft' 60 sec/ min 4.2.2 Gaseous Effluent Dose Rate - Comoliance with 10CFR20 Dose rates resulting from the release of noble gases, and radiciodines and particulates must be calculated to show compliance with 10CFR20. The limits of 10CFR20 are conservatively applied on an instantaneous basis at the hypothetical worst case location.
a) Noble Gases The dose rate in unrestricted areas resulting from noble gas effluents is limited to 500 mrem /yr to the total body and 3000 mrem /yr to the skin. The set point determinations discussed in the previous section are based on the dose calculational method presented in NUREG-0133 (REFERENCE 5.4). They represent a backward solution to the limiting dose equations in NUREG-0133. Setting alarm set trip points in this manner will assure that the limits of 10 CFR 20 are met for noble gas releases. Therefore, no routine dose calculations for noble gases will be needed to show compliance with this part. Routine calculations will be made for doses from noble gas releases to show compliance with 10 CFR 50, Appendix I.
F ORM 372 3643
PUBLIC SERVICE COMPANY OF COLORADO RPAP-2 FORT ST. VRAIN NUCLEAR GENERATING STATION 5 of 23 b) Radiciodine and Particulates and Other Radionuclides The dose rate in unrestricted arlas resulting from the release of radiciodines, tritium and particulates with half lives greater than 8 days is limited to 1500 mrem /yr to any organ.
The calculation of dose rate from radiciodines, tritium and particulates will be performed weekly for all releases. The calculations will be based on the the results of analyses obtained pursuant to the FSV Technical Specifications. To show compliance with 10 CFR 20, Equation 4.15 will be evaluated for I-131, tritium, and radioactive particulates with half lives greater than eight days. Since the gas waste surge tank releases are the major release pathway for tritium, the triti um grab sample analysis results obtained prior to release can be utilized to show compliance with the above dose rate specifications.
IP l- -l 1 i I (X/Q 3) Qis l < 1500 mrem /yr (4.15)
I l_ _l where:
P
= Infant critical organ dose parameter I for radionuclide i for the inhalation pathway mrem /yr per pCi/m' (ATTACH. RPAP-2D);
(X/S)3
= Annual average relative concentration for long-term releases from the stack at the critical location, sec/m' Q $3 = The release rate of radionuclide i from the stack for the week of interest, pCi/sec.
Dose calculations using Equation 4.15 will be made once per week. The source term Q is #III be determined from the results of analysis of weekly reactor stack particulate filters and charcoal cartridges. These source terms include all gaseous releases from FSV. They will be recorded and reported as the total dose for compliance with 10 CFR 20.
FORM 372 22 - 3643
PUBLIC SERVICE COMPANY OF COLORADO RPAP-2 S '
FORT ST. VRAIN NUCLEAR GENERATING STATION f 23 4.2.3 Gaseous Effluents - Comoliance with 10 CFR 50 Doses resulting from the release of noble gases, tritium, radiciodines and particulates must be calculated to show compliance with Appendix I of 10 CFR 50. The calculations will be performed monthly
- or all gaseous effluents.
a) Noble Gas
- 1. Dose Equations The air dose at the critical receptor due to noble gases released in gaseous effluents is determined by Equations 4.16 and 4.17.
For gamma radiation:
-8 3.17 x 10 I M$ l(X/Q)3 *Q33l (4.16) i l_ _I
< 5 mrad for any calendar quarter
< 10 mrad for any calendar year For beta radiation:
_g 3.17 x 10 I N$ l(X/Q)s01sl (4.17) i l_ _I
< 10 mrad for any calendar quarter
< 20 marad for any calendar year l
l where:
1 M = The air dose factor due to l gamma emissions for each l identified noble gas radionuclide i, mrad /yr per l
pCi/m', from ATTACH. RPAp-2C;
~
l FORM 372 - 22 364
PUBLIC SERVICE COMPANY OF COLORADO RPAP-2 FORT ST. VRAIN NUCLEAR GENERATING STATION fssue, 3
t N = The air dose factor due to 3
beta emissions for each identifed noble gas radionuclide i, mrad /yr per pCi/m', from ATTACH. RPAP-2C; (X/C), = The annual average relative
~
concentration for areas at or beyond the site boundary for
-6 stack releases (= 1.37 x 10 sec/m' from ATTACH. RPAP-2B) 3.17x10-8= The inverse of the number of seconds in a year.
- 2. Cumulation of Doses Doses calculated monthly will be summed for comparison with quarterly and annual limits. The monthly results will be added to the doses cumulated from the other months in the quarter of interest and in the year of interest ano compared to the limits given in Equations 4.16 and 4.17. If these limits are exceeded, a Special Report will be submitted to the USNRC in accordance with the FSV Technical Specifications. If twice the limits are exceeded, a Special Report showing compliance with 40 CFR 190 will be submitted.
b) Radioiodine, Particulates, and Other Radionuclides
- 1. Dose Equations The worst case dose to an individual from I-131, tritium, and radioactive particulates with half-lives greater than eight daye in gaseous effluents released to unrestricted areas is determined by the following expressions:
During any calendar quarter or year:
- ~
-8
~
3.17 x 10 I I R ijak IN0 s 1s I J i l_ _I l
< 7.5 mrem (per quarter)
< 15 mrem (per calendar year) (4.18)
FORM 372 22 36t3
PUBLIC SERVICE COMPANY OF COLORADO RPAP-2 FORT ST. VRAIN NUCLEAR GENERATING STATION a 1 of 23 where:
0,9
= Release of radionuclide i for stack releases, uCi; W = Dispersion parameter (X/Q or s
D/Q depending on pathway) for estimating dose to an individual from stack releases; 3.17x10-8= The inverse of the number of seconds in a year; R = The dose factor for each ijak identified radionuclide i, pathway j, age group a, and organ k, m 2mrem /yr per C1/sec or mrem /yr per pCi/m 8 (REFERENCE 5.3).
The above equation will be applied to each combination of age group and organ.
Values of R ijak have been calculated using the methodology given in NUREG-0133 and are given in ATTACH. RPAP-2E. The equation will be applied to a controlling location which will be one of the following: residence, vegetable garden, meat animal, milk animal. The selection of the receptor is discussed in Section i 4.2.3.c.
- 2. Cumulation of Doses Doses calculated monthly will be summed for comparison with quarterly and annual limits. The monthly results will be added to the doses cumulated from the l
other months in the quarter of interest and in the year of interest and compared with the limits in Equation 4.18. If these limits are exceeded, a Special Report will be submitted in accordance with the FSV Technical Specifications.
If twice the limits are exceeded, a Special Report showing compliance with 40 E CFR 190 will be submitted.
F ORM 372 3643
PUBLIC SERVICE COMPANY OF COLORADO RPAP-2 S'
FORT ST. VRAIN NUCLEAR GENERATING STATION 19 of 23 c) Critical Receptor Identification The critical receptors for compliance with 10 CFR 50, Appendix I will be identified. For the noble ges specification the critical location will be based on the external dose pathway only. This location will be the off-site location with the highest X/Q and will be selected using the X/Q values given in (ATTACH. RPAP-2B). This location will be that used for showing compliance with 10 CFR 20 and remain the same unless meteorclogical data is re-evaluated or the site boundary changes.
The critical location for the radioiodine and particulate pathway will be selected once per year. This selection will follow the annual land use census performed within 5 miles of FSV. Each of the following locations will be evaluated as potential critical receptors:
- 1. Residences in each sector
- 2. Vegetable ga'rden producing leafy green vegetables
- 3. All identified milk animal locations.
The critical receptor will be selected based on this evaluation. Following the annual survey, doses will be calculated using Equation 4.18 for all newly identified receptors and those receptors whose characteristics have changed significantly.
The calculation will include appropriate
. information shown to exist at each location.
The dispersion parameters given in this manual should be employed. The total releases reported for the previous calendar year should be used as the source term.
O FORM 372 22 364
PUBLIC SERVICE COMPANY OF COLORADO RPAP-2 FORT ST. VRAIN NUCLEAR GENERATING STATION f888 f 3 4.3 INFORMATION RELATED TO 40 CFR 190 and 40 CFR 141 The Technical Specifications require that when the calculated doses associated with the effluent releases exceed twice the limits of any section, the licensee shall prepare and submit a Special Report to the Commission and limit subsequent releases cuch that the dose or dose commitment to a real individual from all uranium fuel cycle sources is limited to < 25 mrem to the total body or any organ (except the thyroid, which is limited to < 75 mrem) over 12 consecutive months. This Special Report is to include an analysis which demonstrates that radiation exposures to all real individuals from all uranium fuel cycle sources (including all liquid and gaseous effluent pathways and direct radiation) are less than the standards in 40 CFR Part 190, Environmental Radiation Protection Standards for Nuclear Power Operations. If analysis indicates that releases resulting in doses that exceed the 40 CFR 190 Standard may have occurred, then a variance from the Commission to permit such releases will be requested or if possible, action will be taken to reduce subsequent releases. The Technical Specifications consider doses to a real individual and apply to each reactor but do not include any other portion of the uranium fuel cycle or direct shine from the reactor.
The " Uranium fuel cycle" is defined in 40 CFR Part 190.02(b) as:
" Uranium fuel cycle means the operations of milling of uranium ore, chemical conversion of uranium, isotopic enrichment of uranium, fabrication of uranium fuel, generation of electricity by a light-water-cooled nuclear power plant using uranium fuel, and reprocessing of spent uranium fuel, to the extent that these directly support the production of electrical power for public use utilizing nuclear energy, but excludes mining operations, operations at waste disposal sites, transportation of any radioactive material in support of these operations, and the reuse of recovered non-uranium special nuclear and by-product materials from the cycle."
For the purposes of this ODCM, gas-cooled nuclear power plants shall be construed to be part of the " Uranium Fuel Cycle".
FORM 372- 22 360
PUBLIC SERVICE COMPANY OF COLORADO RPAP-2 FORT ST. VRAIN NUCLEAR GENERATING STATION fssue The Special Report will contain:
- 1) A determination of which uranium fuel cycle facilities or operations, in addition to the nuclear power reactor units at the site, contribute to the annual dose to the maximum exposed member of the public. Nuclear fuel facilities over five miles from FSV need not be considered in this determination.
- 2) A determination of the maximum exposed member of the public.
- 3) A determination of the total annual dose to this person from all existing pathways and sources of radioactive effluents and direct radiation using the methodologies described in this ODCM. Where additional information on pathways and nuclides is needed, the best available information will be used and documented.
- 4) A determination of the dose resulting from direct radiation from the plant and storage facilities.
The total body and organ doses resulting from liquid effluents from FSV will be summed with the doses resulting from releases of noble gases, radioiodines and particulates. Tnese doses will be based upon releases from FSV during the past 3 quarters and from the quarter in which twice the specification was exceeded. The . doses from FSV will be summed with the doses to the maximum exposed individual contributed from other operation of the uranium fuel cycle. The direct dose components will be -
determined by either calculation or actual measurement.
4.4 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM 4.1.1 Sampling ATTACH. RPAP-2F specifies the current sampling l locations based on the latest land use census.
1 FORM 372 36C3
PUBLIC SERVICE COMPANY OF COLORADO RPAP-2 FORT ST. VRAIN NUCLEAR GENERATING STATION se g3 If it is learned from an annual census that milk animals or gardens are present at a location which yields a calculated thyroid dose greater than those previously sampled, the new milk animal or garden locations resulting in higher calculated doses shall be added to the surveillance program as soon as practicable. Sample locations (except the control) having lower calculated doses may be dropped from the program at the end of the grazing or growing season (October 31) to keep the total number of sample locations constant.
4.4.2 Interlaboratory Comoarison procram Analyses shall be performed on radioactive samples supplied by the EPA crosscheck program. This program involves the analyses of samples provided by a control laboratory and comparison of results with those of the control laboratory as well as with other laboratories which receive portions of the same samples. Media used in this program (air, milk, water, etc.) may be limited to those found in the radiation environmental monitoring program.
The results of analyses performed as a part of the crosscheck program shall be included in the Annual Radiological Environmental Monitoring Report. The EPA uses the term Estimated Laboratory Precision (ELP), calculated as 3c/N, as the control parameter where N = the number of analyses. Whenever mean valves fall outside of this limit, the sample calculations are rechecked and the sample reanalyzed if possible.
5.0 REFERENCES
5.1 FSV FSAR _
5.2 10CFR20 5.3 RG 1.109, " Calculation of Annual Doses to man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10CFR50, Appendix I", October 1977.
5.4 NUREG -
0133, " Preparation of Radiological Effluent s Tecnnical Specifications for Nuclear Power Plants,"
October, 1978.
FORM 372 - 22 3643
PUBLIC SERVICE COMPANY OF COLORADO RPAP-2 FORT ST. VRAIN NUCLEAR GENERATING STATION 23 of 23 6.0 ATTACHMENTS RPAP-2A A Values for Fort St. Vrain RPAP-2B Annual Average Dilution Factors for FSV RPAP-2C Dose Factors for FSV RPAP-2D P4 Values for an Infant for FSV RPAP-2E R Values for FSV RPAP-2F Radiological Environmental Monitoring Program Sampling Site Descriptions I
FOHM 372 3643
Attacle. RPAP-2A lssue i Page 1 or 2 4
VALUES FOR FORT ST. VRAIN A jT (MREH/HR PER pCl/HL)
NUCLIDE BONE LIVER T. BODY THYRO 10 KIDNEY- LUNG GI-LLI 1H' 3 0.00E-01 1.47E 00 1.47E 00 1.47E 00 1.47E 00 1.4TE 00 1.47E 00 6G 14 3.13E 04 6.26E 03 6.26E 03 6.26E 03 6.26E 03 6.26E 03' 6.26E 03 11NA 24 4.27E 02 4.27E 02 4.27E 02 4.27E 02 4.27E 02 4.27E 02 4.2TE 02 24CR 51 0.00E-01 0.00E-01 1.31E 00 1.90E-01 ?.39E-01 1.73E 00 3.28E 02 25MN 54 0.00E-01 4.43E 03 8.45E 02 0.00E-01 '. 32E 03 0.00E-01 1.360 04 25MN 56 0.00E-01 1.11E 02 1.98E 01 0.00E-01 1.42E 02 0.00E-01 3.56E 03 26FE 55 6.91E 02 4.71E 02 1.11E 02 0.00E-01 0.00E-01 2.66E 02 2.740 02 26FE 59 1.09E 03 2.56E 03 9.83E 02 0.00E-01 0.00E-01 7.160 02 8.540 03 27CO 58 0.00E-01 9.80E 01 2.20E 02 0.00E-01 0.00E-01 0.00E-01 1.99E 03 4 28NI 63 3.270 04 2.26E 03 1.100 03 0.00E-01 0.00E-01 0.00E-01 4.720 02 28NI 65 1.33E O2 1.72E 01 7.87E 00 0.00E-01 0.00E-01 0.00E-01 4.37E 02 29C0 64 0.00E-01 1.10E 01 5.15E 00 0.00E-01 2.76E 01 0.00E-01 9.340 02 30ZN 65 2.32E 04 7.39E 04 3.34E 04 0.00E-01 4.94E 04 0.00E-01 4.66E 04
- 30ZN 69 4.94E 01 9.46E 01 6.58E 00 0.00E-01 6.14E 01 0.00E-01 1.42E 01 35BR 83 0.00E-01 0.00E-01. 4.09E 01 0.00E-01 0.00E-01 0.00E-01 5.89E 01 4 35BR 84 0.00E-01 0.00E-01 5.30E 01 0.00E-01 0.00E-01 0.00E-01 4.16E-04 350R 85 0.00E-01 0.00E-01 2.18E 00 0.00E-01 0.00E-01 0.00E-01 1.020-15 37RB 86 0.00E-01 1.01E 05 4.72E 04 0.00E-01 0.00E-01 0.00E-01 2.000 04 37RO 38 0.00E-01 2.90E 02 1.54E 02 0.00E-01 0.00E-01 0.00E-01 4.01E-09 37RB 89 0.00E-01 1.92E 02 1.35E 02 0.00E-01 0.00E-01 0.00E-01 1.12E-11 38SR 89 2.58E 04 0.00E-01 7.40E 02 0.00E-01 0.000-01 0.00E-01 4.140 03 i 38SR 90 6.35E 05 0.00E-01 1.560 05 0.00E-01 0.00E-01 0.00E "1 1.83E 04 38SR 91 4.75E 02 0.00E-01 1.92E 01 0.00E-01 0.00E-01 0.00E-al 2.260 03 38SR 92 1.80E 02 0.00E-01 7.78E 00 0.00E-01 0.00E-01 0.001-01 3.51E 03 39Y 90 6.90E-01 0.00E-01 1.35E-02 0.00E-01 0.00E-01 0.00E-01 7.32E 03 39Y 92M 6.52E-03 0.00E-01 2.53E-04 0.00E-01 0.00E-01 0.00E-01 1.92r-02 39Y 91 1.010 01 0.00E-01 2.70E-01 0.00E-01 0.00E-01 0.00E-01 5.57E 03 39Y 92 6.06E-02 0.00E-01 1.770-03 0.00E-01 0.00E-01 0.00E-01 1.06E 03 39Y 93 1.92E-01 0.00E-01 5.31E-03 0.00E-01 0.00E-01 0.00E-01 6.100 03 40ZR 95 6.02E-01 1.93E-01 1.31E-01 0.00E-01 3.03E-01 0.00E-01 6.110 02 40ZR 97 3.32E-02 6.71E-03 3.07E-03 0.00E-01 1.01E-02 0.00E-01 2.000 03 4 41NB 95 4.47E 02 2.49E 02 1.34E 02 0.00E-01 2.46E 02 0.00E-01 1.51E 06 42ND 99 0.00E-01 1.54E 02 2.94E 01 0.00E-01 3.50E 02 0.00E-01 3.580 02 431C 99M 1.19E-02 3.34E-02 4.25E-01 0.00E-01 5.07E-01 1.63E-02 1.970 01 42iG101 1.21E-02 1.75E-02 1.72E-01 0.00E-01 3.15E-OI 8.94E-03 5.261-14 44RO103 6.63E 00 0.00E-01 2.86E 00 0.00E-01 2.53E 01 0.00E-01 7.14E n2 44RU105 5.520-01 0.00E-01 2.18E-01 0.00E-01 7.13E 00 0.00E-01 3.300 02 44RU106 9.85E 01 0.00E-01 1.250 01 0.00E-01 1.90E 02 0.000-01 6.39E 03 47AG110M 2.78E 00 2.57E 00 1.53E 00 0.00E-01 5.06E 00 0.00E-01 1.05E 03 SITE 125M 2.60E 03 9.41E 02 3.48E 02 1.81E 02 1.06E 04 0.000-01 1.040 04 52TE127H 6.56E 03 2.350 03 8.00E 02 1.68E 03 2.67E 04 0.00E-01 2.20E 04
, 52TE127 1.07E 02 3.83E 01 2.31E 01 1.90E 01 4.34E 02 0.00E-01 3.42E 0; 52TE129M 1.11E 04 4.16E 03 1.76E 03 3.83E 03 4.65E 04 0.00E-01 5.61F 04 1
R Attach. RPAP-2A isstio 1 Page 2 of 2 A VALUES EOR FORT ST. VRAIN IT (MREM /HR PER pC1/ML)
BONE LIVER T.000Y THYR 010 K10NEY LUNG GI-LLI NUCL10E 52TE129 3.04E 01 1.14E 01 7.42E 00 2.34E 01 1.29E 02 0.00E-01 2.300 01 521E131M 1.68E 03 8.20E 02 6.83E 02 1.30E 03 8.31E 03 0.00E-01 3.14E 04 52TE131 1.91E 01 7.98E 00 6.03E 00 i.57E 01 8.37E 01 0.00E-01 2.700 00 52TE132 2.44E 03 1.58E 03 1.48E 03 1.75E 03 1.52E 04 0.00E-01 7.41E 04 531 130 3.61E 01 1.07E 02 4.21E 01 9.030 03 1.66E 02 0.00E-01 9.180 01 531 131 1.99E 02 2.84E 02 1.63E 02 9.32E 04 4.88E 02 0.00E-01 7.50E 01 2.60E 01 9.0SE 00 9.08E 02 4.130 01 0.00E-Ol 4.88E 00 531 132 9.70E 00 0.00E-01 1.06E O2 531 133 6.79E 01 1.18E 02 3.60E 01 1.74E 04 2.06E 02 531 134 5.07E 00 1.38E 01 4.92E 00 2.39E 02 2.19E 01 0.00E-Of 1.20E-02 531 135 2.12E 01 5.54E 01 2.05E 01 3.66E 04 8.89E 01 0.00E-01 6.26E 01 55CS134 2.99E 05 i.10E 05 5.81E 05 0.00E-01 2.30E 05 7.630 04 1.24E 04 55CS136 3.12E 04 1.23E 05 8.38E 04 0.00E-01 6.86E 04 9.41E 03 1.40E 04 55CS137 3.83E 05 5.23E 05 3.43E 05 0.00E-01 1.78E 05 5.90E 04 1.01E 04 55CS138 2.65E 02 5.23E 01 2.59E 02 0.00E-01 3.84E 02 3.800 01 2.23E-03 56BA139 2.08E 00 1.48E-03 6.10E-02 0.00E-01 1.390-03 8.41E-04 3.69E 00 560A140 4.36E 02 5.47E-01 2.850 01 0.00E-01 1.86E-01 3.130-01 8.97E 02 56BA141 1.01E 00 7.64E-04 3.41E-02 0.00E-01 7.10E-04 4.340-04 4.770-10 57LA140 1.79E-01 9.04E-02 2.39E-02 0.00E-01 0.00E-01 0.00E-01 6.64E 03 57LA142 9.18E-03 4.18E-03 1. 04 E-03 0.00E-01 0.00E-01 0.00E-01 3.05E 01 58CE141 1.34E-01 9.04E-02 1.03E-02 0.00E-01 4.20E-02 0.00E-01 3.46E 02 58CE143 2.36E-02 1.74E 01 1.93E-03 0.00E-01 7.67E-03 0.00E-01 6.510 02 6.97E 00 2.91E 00 3.74E-01 0.000-01 1.73E 00 0.00E-01 2.36E 03 58CE144 0.00F-01 59PR143 6.60E-01 2. 65 E-01 3.27E-02 0.00E-01 1.53E-01 2.890 03
~
59PR144 2.16E-03 8.97E-04 1.10E-04 0.00E-01 5.06E-04 0.000 3.11E-10 60N0147 4.51E-01 5.22E-01 3.12E-02 0.00E-01 3.05E-01 0.00E-01 2.50E 03 74W 187 2.97E 02 2.48E 02 8.68E 01 0.00E-01 0.00E-01 0.00E-Ul 8.13E 04 93NP239 4.26E-02 4.19E-03 2.31E-03 0.000-01 1.31E-02 0.00E-01 8.600 02 a
. .__ _. - __ _ m i
~
Attach..RPAP-2B t
issue 1 i
Page 1 or 1 AVERAGE ANNUAL DILUTION FACTORS FOR FSV
! 7 3 l D l LU T I ON FAC10RS ( 10 - SEC/M )
Corrected f or 'ca lm" l Wind i
Di rect ion (0 ) 590 m 8000 m 16 km 22.5 km r(0 )% 590 m. 8000 m 16 km 22.5 km N 13.33 0.3138 0.0919 0.0508 .17.02 13.71 0.3227 0.0945 0.0522 NNE 7.29 0.1716' O.0503 0.0278 8.40 7.51 0.1767 0.0518 0.0286
! NE 7.49 0.1764 0.0517 0.0285 7.44 7.70 0.1812 0.0531 0.0293 l
l ENE 7.61 0.1792 0.0515 0.0290 6.48 7.82 0.1841 0.9539 0.0298 E 6.34 0.1493 0.0438 0.0242 5.83 6.52 0.1535 0.0450 0.0248 ESE 4.65 0.1094 0.0321 0.0177 4.10 4.79 0.1127 0.0330 0.0182 SE 6.01 0.1414 0.0414 0.0229 5.00 6.18- 0.1455 0.0426 0.0235 SSE 5.91 0.1391 0.0408 0.0225 4.94 6.08 0.1432 0.0420 0.0232 S 8.22 0.1936 0.0567 0.0313 6.18 8.44 0.1987 0.0582 0.0322 SSW 9.27 0.2183 0.0640 0.0353 7.00 9.60 0.2260 0.0662 0.0166 SW 9.82 0.2312 0.0677 0.0374 7.78 10.11 0.2379 0.0697 0.0385 WSW 5.18 0.1220 0.0357 0.0197 5.26 5.33 0.1256 0.0368 0.0204 W 3.16 0.0744 0.0218 0.0120 3.96 3.25 0.0766 0.0244 0.0124-WNW 1.93 0.0454 0.0133 0.0013 2.96 1.98 0.0467 0.0137 0.0076 NW 2.56 0.0611 0.0194 0.0107 3.51 2.90 0.0683 0.0200 0.0110 NNW 2.70 0.0870 0.0255 0.0141 4.14 3.81 0.0896 0.0263 0.0145
i At tacle. RPAP-2C issim 1 Page 1 of 1 I
DOSE FACTORS FOR FSV Total Body Camma Air Octa Air Dose Factor Skin Dose f actor Dose Factor Doso Factor K L M N Radio- l I I I nuclide (arem/yr por pCl/m 3) (arem/yr per pCl/m 3) (mrad /yr por UCi/m 3) (mrad /yr per UCi/m3)
Kr-83m 7.56E-02** ' -------- 1.93E+01 2.88E+02 Kr-55m 1.17E+03 1.46E+03 1.23F+03 1.97E+03 K r-85 1.61E+01 1.34E+03 1.72E+01 1.95E+03 K r-87 5.92E+03 9.73E+03 6.17E+03 1.03E+04 Kr-88 1.47E+04 2.37E+03 1.52E+04 2.93E403 K r-89 1.66E404 1.01E+04 1.73E+04 1.060+04 K r-90 1.56E+04 7.29E+03 1.63E+04 7.83E+03 Xe-131m 9.15E+01 4.76E+02 1.56E+02 1.11E+03 Xe-133m 2.51E+02 9.94E+02 3.27E+02 1.48E+03 l
Xe-133 2.94E+02 3.06E+02 3.53E+02 1.05E+03 l
Xe-135m 3.12E+03 7.11E+02 3.336E+03 7.39E+02 Xe-135 1.81E+03 1.86E+03 1.92E+03 2.460+03 Xe-137 1.42E+03 1.22E+04 1.51E403 1.27E404 Xe-138 8.83E+03 4.13E+03 9.21E+03 4.75E+03 l
1 Ar-41 8.84E+03 2.69E+03 9.30E+03 3.28E403
- 7.56E-02 = 7.56 x 10 2
PUBLIC SERVICE COMPANY OF COLORADO Attach. RPAP-20 ssue FORT ST. VRAIM NUCLEAR GENERATING STATION P VALUES FOR AN INFANT FOR FSV 3
Isotooe Inhalation Ground Plane Cow Milk Goat Milk H-3 6.47E2 0 2.38E3 4.86E3 P-32 2.03E6 0 1.60E11 1.93E11 Cr-51 1.28E4 6.67E6 4.79E6 5.65E5 Mn-54 1.00E6 1.09E9 3.89E7 4.6SE6 Fe-59 1.02E6 3.92EB 3.93E8 5.11E6 Co-58 7.77E5 5.29E8 6.06E7 7.28E6 Co-60 4.51E6 4.40E9 2.10E8 2.52E7 Zn-65 6.47ES 6.89E8 1.90E10 2.29E9 Rb-86 1.90E5 1.28E7 2.22E10 2.67E9 Sr-89 2.03E6 3.16E4 1.27E10 2.66E10 Sr-90 4.09E7 -
1.21E11 2.55E11 Y-91 2.45E6 1.52E6 5.26E6 6.32E5 Zr-95 1.75E6 3.48E8 8.28E5 9.95E4 Nb-95 4.79E5 1.95E8 2.06E8 2.48E7 Ru-103 5.52E5 1.55E8 1.05E5 1.27E4 Ru-106 1.16E7 2.99E8 1.44E6 1.73E5 Ag-110m 3.67E6 3.14E9 1.46E10 1.75E9 Te-127m 1.31E6 1.18E5 1.04E9 1.24E8 Te-129m 1.68E6 2.86E7 1.40E9 1.68E8 Cs-134 7.03E5 2.81E9 6.79E10 2.04E11 Cs-136 1.35E5 2.13E8 5.76E9 1.73E10 Cs-137 6.12E5 1.15E9 6.02E10 1.81E11 Ba-140 1.60E6 2.94E7 2.41E8 2.89E7 Ce-141 5.17E5 1.98E7 1.37E7 1.65E6 Ce-144 9.84E6 5.84E7 1.33E8 1.60E7 I-131 1.48E7 2.46E7 1.06E12 1.27E12 I-132 1.69ES 1.78E6 1.39E2 1.64E2 I-133 3.56E6 3.54E6 9.80E9 1.18E10 I-135 6.96E5 3.67E6 2.27E7 2.68E7 Units are mrem /yr per pCi/m 8for H-3 and the inhalation pathway and mrem /yr per pCi/sec per m -2 for the food and ground plane pathways.
I FORM 372 - 22 364
(
Attach. RPAP-2E issuo 1 Page 1 or 19 R VALUES FOR ISV*
PATitWAY = CROUND -
NUCLlDE T. BODY GI-lRACT . DONE LIVER KlDNEY TilYRo l D LUNG SKIN i CR 51 4.66E 06 4.66E 06 4.66E 06 4.66E 06 4.66r. 06 4.66E 06 4.66E 06 5.51f 06 MN 54 1.34E 09 ~ 1.34E 09 1.34E 09 1.34E 09 1.34E 09 1.34E 09 1.34E 09 1.57E 09 rE 59 2.75E 08 2.75E 08 2.75E 08 2.75E 08 2.750 08 2.750 08 2.75E 08 3.230 08 CO 58 3.79E 08 3.79E 08 3.79E 08 3.79E 08 3.79E 08 3.79E 08 3.79E 08 4.441. 08 CO 60 2.150-10 2.15E 10 2.15E 10 2.15E 10 2.15E 10 2.15E 10 2.15E 10 2.52E 10 ZN 65 7.49E 08 7.49E 08 7.49E 08 7.49E 08 7.49E 08 7.49E 08 7.49E 08 8.610 08 SR 89 2.23E 04 2.23E 04 2.23E 04 2.23E 04 2.23E 04 2.23E 04 2.23E 04 2.58E 04 ZR 95 2.49E 08 2.49E 08 2.49E 08 2.49E 08 2.49E 08 2.49E 08 2.49E 08 2.89E 08 1 131 1.72E 07 1.72E 07 1.72E 07 1.72E 07 1.72E 07 1.72E 07 1.72E GT 2.09E OT I 133 2.47E 06 2.47E 06 2.47E 06 2.47E 06 2.47E 06 2.47E 06 2.47E 06 3.000 06 CS134 6.82E 09 6.82E 09 6.82E 09 6.82E 09 6.82E 09 6.82E 09 6.82E 09 7.96E 09 CS 136 1.49E 08 1.49E 08 1.49E 08 1.49E 08 1.49E 08 1.49E 08 1.49E 08 1.69E 08 CS137 1.03E 10 1.03E 10 1.03E 10 1.03E 10 1.03E 10 1.03E 10 1.03E 10 1.20E 10 BA140 2.05E 07 2.03E 07 2.05E 07 2.050 07 2.05E OT - 2.05E 07 2.05E 01 2.34F 07 CE141 1.36E OT 1.36E 07 1.36E 07 1.36E 07 1.36E 07 1.36E 07 1.36E 01 1. 5 31: 07 4
i
- P values in units or arem/yr per micro-Cl/m3 for inhalation and tritium, and in units or H I ' -ares /yr per micro-CE /sec for a ll others d
.b At tacle. RPAP-2E Issue i Page 2 or 19 R VALUES FOR FSV' PATOWAY = VECET AGE CROUP EQUALS ADULT NOCLIOE T. BODY GI-TRACT BONE LIVER KIDHEY TilYROID LUNG SKIN 11 3 2.28i' 03 2.28E 03 0.00E-01 2.28E 03 2.28E 03 2.280 03 2.28E 03 2.200 03 CR 51 4.60E 04 1.16E 07 0.00E-01 0.00E-01 1.01E 04 2.750 04 6.100 04 0.00E-01 MN 54 5.83E 07 9.36E 08 0.00E-01 3.05E 08 9.09E OT 0.00E-01 0.00E-01 0.00E-01 FE 59 1.12E 08 9.75E 08 1.24E 08 2.93E 08 0.00E-01' O.00E-01 8.17f of 0.000-01 CO 58 6.17E 07 6.07E 08 0.00E-01 2.99E 07 0.00E-01 0.00E-01 0.00E-01 0.00E-Ol CO 60 3.67E 08 3.12E 09 0.00E-01 1.66E 08 0.00E-01 0.00E-01 0.00E-Ol 0.000-01 ZN 65 5.770 08 8.04E 08 4.01E 08 1.28E 09 8.54E 08 0.00E-01 0.00E-01 0.000-01 7 SR 89 2.87E 08 1.60E 09 1.00E 10 0.00E-01 0.00E-01 0.00E-01 0.00L-01 0.00E-01 SR 90 1.64E 11 1.93E 10 6.70E 11 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 ZR 95 2.51E 05 1.17E 09 1.16E 06 3.71E 05 5.82E 05 0.00E-01 0.00E-01 0.00E-01 1 131 6.61E 07 3.04E 07 8.07E 07 1.15E 08 1.98E 08 3.78E 10 0.000-01 0.00E-01 1 133 1.12E 06 3.30E 06 2.11E 06 3.67E 06 6.40E 06 5.39E 08 0.000-01 0.000-01 CS134 8.83E 09 1.89E 08 4.54E 09 1.08E 10 3.49E 09 0.00E-01 1.16E 09 0. 001~ - 01 1
CS136 1.19E 08 1.88E OT 4.19E 07 1.66E 08 9.21E 07 0.00E-01 1.?6E 01 0.00E-01 CS137 5.94E 09 1.76E 06 6.63E 09 9.07E 09 3.08E 09 0.00E-01 1.02E 09 0.000-01 BA140 8.40E 06 2.64E 08 1.28E 08 1.61E 05 5.47E 04 0.00E-01 9.220 04 0.00E-01 CE141 1.48E 04 4.99E 08 1.93E 05 1.31E 05 6.07E 04 0.00E-01 0.00E-01 0.000-01
- R2 values in units of mrom/yr per micro-Ci/m) for inhalation and tritium, and in units or M -mrem /yr per micro-Ci/sec for all others
A t tacli . RPAP-2E Issten 1 Pago 3 or .19 R VALUES FOR FSV PATifWAY = VECET ACE CROUP EQUALS TEEN i
NOCLIDE T.800Y Cl-TRACT 80NE LIVER KIDNEY TilYROID LONC SKIN li 3 2.61E 03- .2.610 03 0.00E-01 2.6tE 03 2.61E 03 2.610 03 2.6tE 03 2. 6 11 03 CR 51 6.110 04 1.03E 07 0.00E-01 0.00E-01 1.34E 04 3.39E 04 8.120 04 0.00E-01 j MN 54 '8.79E 07 9.09E 08 0.00E-01 4.43E 08 1.32E 08 0.00E-01 0.00E-01 0.00E-01
- FE 59 1.60E 08 9.78E 08 1.77E 08 4.14E 08 0.00E-01 0.00E-01 1.30E 08 0.00E-01 j CO 58 9.79E 07 5.85E 08 0.00E-01 4.25E 07 0.00E-01 0.00E-01 0.00E-01 0.00E-01 1
i CO 60 5.57E 08 3.22E 09 0.00E-01 2.47E 08 0.00E-01 0.00E-01 0.00E-01 .0.00E-01 ZN 65 8.68E OS 7.88E 08 5.36E 08 1.86E 09 1.19E 09 0.00E-01 0.00E-01 'O.001-01 SR 89 4.36E 08 1.81E 09 1.52E 10 0.00E-01 0.00E-01 0.00E-01 0.000-01 0.000-01 SR 90 2.05E 11 2.33E 10 8.32E 11 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 ZR 95 3.68E 05 1.23E 09 1.690 06 5.35E 05 7.86E 05 0.00E-01 0.00E-01 0.00f-01 1 131 5.77E 07 2.13E 07 7.68E 07 1.07E 08 1.85E 08 3.14E 10 0.00E-01 0.00E-01 1 1 133 1.01E 06 2.51E 06 1.96E 06 3.32E 06 5.83E 06 4.64E 08 0.00E-01 0.00E-01 CS134 7.54E 09 2.02E 08 6.90E 09 1.62E 10 5.1;E 09 0.00E-01 1.97E 09 0.00E-01 CS136 1.13E 08 1.35E 07 4.28E 07 1.68E 08 9.16E 07 0.00E-01 1.44E OT 0.00E-01 CS137 4.90E 09 2.00E Od 1.06E 10 1.41E 10 4.78E 09 0.00E-01 1.860 09 0.00E-01 j DA140 8.88E 06 2.12E 08 1.38E 08 1.69E 05 5.72E 04 0.00E-01 1.140 05 0,00E-01 CE141 2.12E 04 5.29E 08 2.77E 05 1.85E 05 8.70E 04 0.00E-01 0.00E-01 0.00E-01
{
i i
a
- R values in units or mrom/yr por micro-Ci/m 3 for Inhalation and tritium, and in units or
! M 2 -mrom/yr per micro-Ci/sec for all ot hers l
.7 ,
Attacts. nPAP-20 issuo 1
-Page 4 Of I9 R VALUES FOR FSV*
PATHWAY = VEGET AGE CROUP EQUALS CHILD NUCLIDE- T. BODY GI-TRACT BONE LIVER KIDNEY THYROID LUNG SKIN H 3 4.04E 03 4.04E 03 0.00E-01 4.04E 03 4.04E 03 4.04E 03 4.04E 03 4.04E 03
.CR 51 1.16E 05 6.15E 06 0.00E-01 0.00E-01 1.76E 04 6.44E 04 1.18E 05 0.000-01 MN 54 1.73E 08 5.44E 08 0.00E-01 6.49E 08 1.82E 08 0.00E-01 0.00E-01 0.00E-01 FE 59 3.17E 08 6.62E 08 3.93E 08 6.36E 08 0.00E-01 0.00E-Ol 1.84E 08 0.00E-01 CO 58 1.92E 08 3.66E 08 0.00E-01 6.27E 07 0.00E-01 0.00E-01 0.00E-01 0.00E-01 CO 60 1.11E 09 .208E 09 0.000-01 3.76E 08 0.00E-01 0.00E-01 0.00E-01 0.00E-01 ZN 65 1.70E 09 4.81E 08 1.03E 09 .2.74E 09 1.73E 09 0.00E-01 0.00E-01 0.00E-01 SR 89 1.03E 09 1.40E 09 3.62E 10 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 SR 90 3.49E 11 1.86E 10 1.38E 12 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 ZR 95 7.44E 05 8.71E 08 .. 3.80E 06 8.35E 05 1.20E 06 0.00E-01 0.00E-01 0.00E-01 1 131 8.16E 07 1.28E 07 1.41E 08 1.44E 08 2.36E 08 4.75E 10 0.00E-01 0.00E-01 1 133 1.67E 06 1.78E 06 3.57E 06 4.42E 06 7.36E 06' 8.21E 08 0.00E-01 0.00E-01 CS134 5.40E 09 1.38E 08 1.56E 10 2.56E 10 7.93E 09 0.00E-03 2.84E 09 0.000-01 CS136 1.43E 08 7.77E 06 8.04E 07 2.21E 08 1.18E 08 0.00E-01 1.76E 07 0.00E-01 CS137 3.52E 09 1.50E 08 2.48E 10 2.39E 10 7.70E 09 0.00E-01 2.800 09 0.000-01 BA140 1.61E 07 1.40E 08 2.76E 08 2.42E 05 7.87E 04 0.00E-01 1.44E 05 0.001-01 CE141 4.75E 04 3.99E 08 6.42E 05 3.200 05 1.40E 05 0.00E-01 0.00E-01 0.00E-01
- R alues in units or mrem /yr per micro-Ci/m for inhalation and tritium, and in units or M2 -erem/yr por micro-Ci/sec for all others
c-At tach. ' RPAP-2E issue 1
> Pago 5 of 19' R VALUES FOR FSV*
PATilWAY = MEAT ACE CROUP EQUALS ADULT NUCLIDE T.000Y GI-TRACT BONE LIVER K10NEY TilVR010 LUNG SKIN ll 3 3.210 02 3.2EE 02 0.00E-01 3.21L 02 3.2il 02 3.210 02 3.21L 02 3 . 2 11 02 CR 51 3.26E 03 8.21E 05 0.00E-01 0.00E-01 7.19E 02 1.95E 03 4.33E 03 0.00I-01 MN 54 8.98E 05 1 .48:0 07 0.00E-01 4.71E 06 1.40E 06 0.00E-01 0.00E-01 0.00E-01
- IE 59 1.12E 08 9.73E 08 1.28sE 08 2.92E 08 0.00E-01 0.00E-01 8.160 07 0.000-01 i
Co 58 1.95E 07 1.76E 08 0.00E-01 8.68E 06 0.00E-01 0.00E-01 0.000-01 0.00E-01
- CO 60 8.87E 07 7.55E 08 0.00E-01 4.02E 07 0.00E-01 0.00E-01 0.00E-01 0.00L-01 ZN 65 3.06E 08 4.27E 08 2.13E 08 6.78E 08 4.53E 08 0.00E-01 0.00E-01 0.00E-01 SR 89 4.12E 06 2.30E 07 1.43E 08 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01
- SR 90 1.76E 09 2.07E 08 7.17E 09 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 ZR 95 1.94E 05 9.07E 08 8.92E 05 2.86E 05 .4.490 05 0.00E-01 0.000-01 0.00L-01 1 131 4.33E 06 1.99E 06 5.28E 06 7.55E 06 1.29E 07 2.400 09 0.000-01 0.001'-01 1 133 1.13E-01 3.34E-01 2.18.E-01 3.72E-01 6. fi9 E-01 5.46E 01 0.00E-01 0.00E-Oi CS134 6.68E 08 1.43E 07 2.PfE 08 8.17E 08 2 . 68 E 08 0.00E-01 8.78E 07 0.00E-01 CS136 1.61E OT 2.53E 06 5.65E 06 2.23E 07 1.21sE 07 ,
0.00E-01 1.70E 06 0.00E-01 CS137 4.33E 08 1.2dE 07 4.83E 08 6.61E 00 2.28sE 08 0.00E-01 7.l6E OT 0.00E-01 BA140 9.01E 05 2.83E 07 1.38E 07 1.73E 04 5.87E 03 0.00E-01 9.89E 03 0.00E-01 i CE141 4.96E 02 1.67E 07 6.47E 03 4.38E 03 2.03E 03 0.00E-01 0.00E-01 0.00E-01 i
l I
i
- R values in units or mrem /yr por micro-Ci/sh for inhalation and tritium, and in units of M2 -arem/yr per micro-Ci/sec for all others t
j 4
Attach. RPAP-2E issue 1 Page 6 or 19 R VALUES FOR ISV" PATilWAY = MEAT ACE CROUP EQUALS TEE 1 NUCLIDE T. BODY GI-1RACT BONE LIVER KIDNEY THYRolD LUNG SKIN li 3 1.950 02 1.95E 02 0.00E-01 .1.95E 02 1.95E 02 1.950 02 1.950 02 1.95E 02 CR 51 2.61E 03 4.39E 05 0.00E-01 0.00E-01 5.72E 02 1.45E 03 3.73E 03 0.00E-01.
NN Sfs 7.12E 05 7.37E 06 0.00E-01 3.59E 06 1.01E 06 0.00E-01 0.00E-01 0.00E-01 FE 59 8.95E 07 5.48E 08 9.93E 07 2.32E 08 0.000-01 0.00E-01 7.31E 01 0.00E-01 Co 58 1.5fE 07 9.22E of 0.00E-01 6.69E 06 0.00E-01 0.00E-01 0.00E-01 0.00f-01 CO 60 7.03E 07 is.06E 08 0.00E-01 3.120 07 0.00E-01 0.00E-01 0.00E-01 0.00E-01 ZN 65 2.43E 08 2.20E 08 1.50E 08 5.20E 08 3.33E 08 0.00E-01 0.00E-01 0.000-01 SR 89 3.47E 06 1.ftisE 97 1.21E 08 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.000-01 J
i SR 90 1.15E 09 1.30E 08 4.64E 09 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.000-01 ZR 95 1.55E 05 5.20E 08 7.15E 05 2.25E 05 3.31E 05 0.00E-01 0.000-01 0.00E-01
- i 131 3.30E 06 1.22E 06 4.38E 06 6.140 06 1.06E 07 1.79E 09 0.00E-01 0.00E-01 i 133 9.25E-02 2.30E-01 1.79E-01 3.03E-01 5.32E-01 4.230 01 0.00E-01 0.001-01 1
CSl34 2.98E 08 7.99E 06 2.730 08 6.4PE 08 2.08sE 08 0.00E-01 7.78E 01 0.00f-OI CS136 1.16E 07 1.400 06 4.41E 06 1.73E 07 9.484E 06 0.00E-01 1.49E 06 0.00E-01
] CS137 1.86E 08 7.59E 06 4.01E 08 5.34E 08 1.82E 08 0.00E-01 7.060 07 0.00E-01 Ball io 7.33E 05 1.75E 07 1 . 13 E 07 1.39E 04 4.72E 03 0.00E-01 9.37E 03 0.00l-01 i
l CE1841 4.17E 02 1.04E 07 5.43E 03 3.63E 03 1.71E 03 0.00E-01 0.00E-01 0.00l-01
]
1 i
I "P2values in units or mrem /yr per micro-Cl/sh for inhalation and tritium, and in units or M -mrom/yr per micro-Ci/sec for all others 1
4
Attacts. R PA P-20 issuo 1 Pogo I or 19 R VALUES FOR FSV' PATilWAY = HEAT AGE GROUP EQUALS CillLD NOCLIDE T. BODY GI-1RACT BONE LIVER K10NEY lilYR010 IUNG SKIN li 3 2.36L 02 2.36L 02 0.00L-01 2.36L 02 2.36L 02 2.360 02 2.36L 02 2.36l 02 CR 51 4.OTE 03 2.16E 05 0.00E-01 0.00E-01 6.17[ 02 2.260 03 4.12L 03 0.00E-01 HN 54 1.09E 06 3.45E 06 0.00E-01 4.11E 06 1.15E.06 0.000-01 0.00E-01 0.000-01 IE 59 1.42E 08 2.97E 08 1.76E 08 2.85E 08 0.00E-01 0.00E-Of 8.26E Of 0.001-01 CO 58 2.39E 07 4.560 07 0.00E-01 7.82E 06 0.00E-01 0.00E-01 0.00E-Ol -0.00E-01 CO 60 1.09E 08 2.05E 08 0. 00 E-01 3.70E 07 0.00E-01 0.00E-01 0.00E-01 0.00L-01 ZN 65 3.72E 08 1.05E 08 2.25E 08 5.99E 08 3.77E 08 0.00E-01 0.00E-01 0.00E-01 SR 89 6.55E 06 8.87E 06 2.29E 08 0.000-01 0.00E-01 0.00E-01 0.00E-01 0.00F-01 SR 90 1.52E 09 8.08E 07 6.00E 09 0.00E-01 0.00E-01 0.00F-01 0.00E-01 0.00L-01 ZR 95 2.48E 05 2.91E 08 1.27E 06 2.79E 05 3.99E 05 0.00E-01 0.00E-01 0.001.-01 1 131 4.65E 06 7.29E 05 8.14E 06 8.19E 06 1.34E 07 2.71E 09 0.00E-01 0.00E-01 1 133 1.55E-01 1.66E-01 3.32E-01 4.11E-01 6.85E-01 7.63E 01 0.00E-01 0.00E-01 CS134 1.67E 08 4.26E 06 4.81E 08 7.900 08 2.45E 08 0.00E-01 8.78F 07 0.00E-01 CS136 1.35E 07 7.34E 05 7.60E 06 2.09E 07 1.11E 07 0.00E-01 1.66E 06 0.00E-01 CS137 1.04E 08 4.43E 06 7.38E 08 7.07E 08 2.30E 08 0.00E-01 8.29E 07 0.00E-01 BA140 1.220 06 1.06E 07 2.10E 07 1.84E 04 5.98E 03 0.00E-01 1.100 04 0.0GE-01 CE141 7.57E 02 6.36E 06 1.02E 04 5.10E 03 2.24E 03 0.00E-01 0.00E-01 0.00L-01
- R2 values in units of mrem /yr per micro-Ci/sf for inhalation and tritium, and in units of H -mrem /yr per micro-Ci/sec for all ottiers
i l
l Attacle. RPAP-2E lasuo 1 Page 8 or 19
-R VALUES FOR FSV*
l- PATifWAY = COW MILK ACE CROUP EQUALS ADULT NUCLIDE T. BODY Cl-TRACT BONE LIVER KIDNEY THYRotD LUNG SKIN CR 51 1.32E 04 3.32E 06 0.00E-01 .0.00E-01 2.91E 03 7.900 03 1.78E 04 0.00E-01 HN 54 8.25E 05 1.32E OT 0.00E-01 4.32E 06- 1.29E 06 0.00E-01 0.00E-01 .0.00E-01 FE 59 1.25E 07 1.09E 08 1.39E 07 3.26E 07 0.00c-01 0.00E-01 9.10E 06 0.00F-01 CO 58 5.03E 06 4.55E 07 0.00E-01 2.24E 06 0.00E-01 0.00E-01 0.00E-01 0.001.-01 CO 60 1.93E 07 1.65E 08 0.00E-01 8.77E 06 0.00E-01 0.00E-01 0.00E-01 0.00E-01 ZN 65 1.18E 09 1.65E 09 8.21E 08 2.61E 09 1.750 09 0.00E-01 0.00E-01 0.00E-01 SR 89 1.97E 07 1.10E 06 6.85E 08 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.000-01 SR 90 6.62E 09 7.80E 08 2.70E 10 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 ZR 95 9.72E 01 4.55E 05 '4.48E 02 1.44E 02 2.25E 02 0.00E-01 0.002-01 0.000-01 1 131 1.19E 08 5.49E 07 1.45E 08 2.08E 08 2.57E 08 6.82E 10 0.00E-01 0.000-01 1 133 1.05E 06 3.09E 06 1.98E 06 3.44E 06 6.01E 06 S.06E 08 0.00E-01 0.000-01 CS134 S.74E 09 1.230 08 2.95E 09 7.02E 09 2.27E 09 0.00E-01 7.54E 08 0.00t-01 CS136 3.55E 08 5.60E 07 1.25E 08 4.93E 08 2.74E 08 0.00E-01 3.76E 07 0.00E-01 CS137 3.66E 09 1.08E 08 4.09E 09 5.59E 09 1.90E 09 0.00E-01 6.31E 08 0.00E-01 BA140 8.43E 05 2.65E 07 1.29E 07 1.62E 04 5.49E 03 0.00E-01 9.2SE 03 0.00E-01 CE141 1.71E 02 5.78E 06 2.24E 03 1.51E 03 7.02E 02 0.00E-01 0.00E-01 0.00E-01 1
1 3
- P values in units or mrcs/yr por micro-Ci/m for inhalation and tritium, and in units of M 2-mres/yr per micro-Ci/sec for all ottiers l
4 Attach. RPAP-2E Issue 1
- Pago 9 of 19 R VALUES FOR ISV*
PATHWAY = COW MILK AGE GROUP EQUALS TEEN NUCLIDE T. BODY GI-TRACT RONE -LIVER KIDNEY THYROID LUNG SKIN 11 3 1.00E 03 1.00E 03 0.00E-01 1.00E 03 1,00E 03 1.000 03 1.000 03 1.00t~03 CR 51 2.31E 04 3.88E 06 0.00E-01 0.00E-01 5.06E 03 1.28E 04 3.30E 04 0.00E-01
- HM 54 1.43E 06 1.48E 07 0.00E-01 7.20E 06 2.150 06 0.00E-01 .0.00E-01 0.00E-01 4
FE 59 2.18E 07 1.34E 08 2.42E 07 5.65E 07 0.00E-01 0.00E-01 I.78E 07 0.00E-01 CO 58 8.70E 06 5.21E 07 0.00E-01 3.78E 06 0.00E-01 0.00E-01 0.00E-01 0.00E-01 CO 60 3.35E 07 1.94E 08 0.00E-01 1.49E 07 0.00E-01 0.00E-01 0.00E-01 ~ 0.00E ZN 65 - .2.04E 09 1.85E 09 1.26E 09 4.38E 09 2.80E 09 0.00E-01 0.00E-01 0.00E-01 SR 89- 3.62E 07 1.50E 08 1.26E 09 0.00E-01 0.00E-01 0.00E-01, 0.00E-01 0.00E-01
]
SR 90 9.42E 09 1.07E 09 3.81E 10 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 ZR 95 1.70E 02 5.70E 05 7.83E 02 2.47E 02 3.63E 02 0.00E-01 0.00E-01 0.00E-01 1 131 1.98E 08 7.31E 07 2.64E 08 3.69E 08 6.36E 08 1.08E 11 0.00E-01 0.00E-01 1 133 1.87E 06 4.64E 06 3.61E 06 6.13E 06 1.08E 07 8.56E 08 0.00E-01 0.00E-01 CS134 5.60E 09 1.50E 08 5.12E 09 1.21E 10 3.83E 09 0.00E-01 1.46E 09 0.00E-01 CS136 5.62E 08 6.73E 07 2.13E 08 8.37E 08 4.55E 08 ,
- 0. 00 E-01 7.18E 07 0.00I-01 j CS137 3.44E 09 1.40E 08 7.42E 09 9.87E 09 3.36E 09 0.00e-01 1.30E 09 0.00E-01 RA140 1.50E 06 3.58E 07 2.32E 07 2.84E 04 9.65E 03 0.00E-01 1.91E 04 0.00E-01 1
CE141 3.14E 02 7.83E 06 4.10E 03 2.74E 03 1.29E 03 0.00E-01 0.00E-01 0.00f-01 i
3
- Ry values in units or mres/yr por micro-Ci/m for inhalation and tritium, and in units or W 'arem/yr per micro-Cl/sec for all others i
At tacle. RPAP-2I issue 1-Pago 10 or 19 R VALUES FOR ISV*
PATilWAY = COW MILK ACE CROUP EQUALS CHILD' NOCLIDE T. BODY GI-TRACT BONE LIVER KIDNEY TilYR0lO LUNG SKIN-H 3 1.58E 03 1.580 03 0.00E-01 1.580 03 1.58E 03 1.58E 03 1.58E 03 1.580 01 CR 51 4.71E 04 2.50E 06 0.00E-01 0.00E-01 7.14E 03 2.6tE 04 4.71E 04 0.00E-01 a
MN 54 2.87E 06 9.04E 06 0.00E-01 1.08E 07 3.02E 06 0.00E-01 0.00E-01 0.00E-01 FE 59 4.52E 07 9.45E 07 5.61E 07 9.08E 07 0.00E-01 0.00E-01 2.63E 07 0.00f-01 CO 58 1.77E 07 3.37E 07 0.00E-01 5.77E 06 0.00E-01 0.00e-01 0.00E-Ul 0.00I-01 CO 60 6.81E 07 1.28E 08 0.00E-01 2.31E 07 0.00E-01 0.00E-01 0.00E-01 0.00r-01 ZN 65 4.10E 09 1.16E 09 2.47E 09 6.59E 09 4.15E 09 0.00E-01 0.00E-01 0.00E-01 SR 89 8.93E 07 1.210 08 3.13E 09 0.00E-01 0.00E-01 0.00E-01 0.00f.-01 0.000-01 I
SR 90 1.63E 10 8.68E 08 6.44F 10 0.00E-01 0.000-01 0.00E-01 0.00E-01 0.00E-01 ZR 95 3.56E 02 4.17E 05 1.82E 03 4.00E 02 5.720 02 0.00E-01 0.00E-01 0.00E-01 1 131 3.66E 08 5.73E 07 6.40E 08 6.44E 08 1.06E 09 2.13E 11 0.00E-01 0.00E-01 l 133 -4.11E 06 4.38E 06 8.78E 06 1.09E 07 1.81E 07 2.02E 09 0.00E-01 0.00I-Of l
CS134 4.09E 09 1.05E 08 1.18E 10 1.94E 10 6.01E 09 0.00E-01 2.16E 09 0.001.-01 h CS136 8.53E 08 4.63E 07 4.80E 08 1.32E 09 7.02E 08 0.00E-01 1.050 08 0.000-01 CSf37 2.52E 09 1.07E 08 1.79E 10 1.71E to 5.57E 09 0.00E-01 2.00E 09 0.00E-01 BA140 3.27E 06 2.84E 07 5.60E 07 4.91E 04 1.60E 04 0.00E-01 2.930 04 0.00E-01 CE141 7.47E 02 6.28E 06 1.01E 04' 5.03E 03 2.21E 03 0.00E-01 0.00E-01 0.00E-01 l
i
- R2 values in units or mrem /yr per micro-Cl/d for inhalation and tritium, and in units of j M -ares /yr per micro-Ci/sec for all others i
k, r_
Attach.'RPAP-2E issue 1 fage 11 or,19
. R VALUES FOR ISV*
PATifWAY = COW HILK ACE CROUP EQUALS INrAN1 NUCL10E T. BODY GI-TRACT BONE LIVER K10NEY lilVR010 LONG SKIN 11 3 2. 8:0E 03 2.180E 03 0.00L-UI 2. 8:0E 03 2. 8:0L 03 2.8 0E 03 4 2.80E 4 03 2.100 03 CR 51 7.46E 088 2.17E 06 0.00E-01 0.00E-01 1.06E 07 Is.87E 08: 9.810 084 4 0.00t-01 MN Sie 4.584E 06 7.36E 06 0.00E-01 2.00E 07 I.48sE I 06 0.00E-01 0.00E-01 0.00E-01 rE 59 7.21E 07 8.74E 07 1.05E 08 1.83E 08 0.00E-01 0.00E-01 5.41E 07 0.00E-01 CO 58 2.88E 07 2.88E 07 0.00E-01 1.15E 07 0.00E-01 0.00E-01 0.00E-01' O.000-01 CO 60 1.11E 08 1.12E 08 0.00E-01 4.71E 07 0.00E-01 0.00E-01 0.00E-01 0.001.-01 ZN 65 5.26E 09 9.63E 09 3.32E 09 1.18sE 10 5.53E 09 0.00E-01 0.00E-01 0.00E-01 i SR 89 1.70E 08 1.22E 08 5.94E 09 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00o-01 SR 90 1.79E 10 8.75E 08 7.01E 10 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.000-01 ZR 95 5.5bt 02 3.92E 05 3.23E 03 7.87E 02 8.l:8E 02 0.00E-01 0.00E-01 0.00L-01 1 131 6.92E 08 5.62E 07 1.34E 09 1.57E 09 1.8fE l 09 5.17E 11' O.00E-01 0.00E-01 1 133 7.91E 06 4.57E 06 1.85E 07 2.70E 07 3.17E 07 ft.91E 09 0.000-01 0.00r-01 CS134 3.590 09 9.65E 07 1.90E 10 3.55E 10 9.11Et 09 0.00E-01 3.75E 09 0.000-01 CS136 1.030 09 8.19E 8 07 9.37E 08 2.76E 09 1.10E 09 0.00E-01 2.25E 08 0.00E-01 CS137 2.37L 09 l 1.OiE 08 2.85E 10 3.3fsE 10 8.96E 09 0.00E-01 3.63E 09 0.00r-01 Ball:0 5.9fsE 06 2.83E 07 1.15E 08 1.15E 08 2.740 04 0.00E-01 7.08E 08: 0.000-01 CE141 1.44E 03 6.30E 06 2.00E 084 1.22E 04 3.76E 03 0.00E-01 0.00E-01 0.00E-01 1
1 *R values in units or mrem /yr por micro-Ci/m for inhalation and tritium, and in units or
! M 2-arem/yr per micro-Cl/sec for all others
.1
Attach. HPAP-20 issuo 1 Page 12 or 19 R VALUES FOR FSV*
PATHWAY = GOA1 MILK AGE GROUP EQUALS ADULT NOCLIDE T.B00Y GI-TRACT BONE LIVERKlDNEY THYROID LUNG SKIN 11 3 1.510 03 1.51E 03 0.00E-01 1.57E 03 1.57E 03 1.51E 03 1.57E 03 1.57E 03 CR 51 1.59E 03 3.99E 05 0.00E-01 0.00E-01 3.49E 02 9.48E 02 2.11E 03 0.001-01 MN 54 9.890 04 1.59E 06- 0.00E-01 5.19E 05 1.54E 05 0.00E-01 0.00E-01 0.00E-01 FE 59 1.62E 05 1.41E 06 1.80E 05 4.23E 05 0.00E-01 0.00E-01 1.180 05 0.00E-01 CO 58 6.03E 05 5.46E 06 0.00E-01 2.69E 05 0.70E-01 0.00E-01 0.000-01 0.00E-01' CO 60 2.32E 06 1.98E 07 0.00E-01 1.05E 06 0.00E-01 0.00E-01 0.00E-01 0.00E-01 ZN 65 1.42E 08 1.97E 08 9.85E 07 3.14E 08 2.10E 08 0.00E-01 0.00E-01 0.000-01 SR 89 4.13E 07 2.31E 08 1.44E 09 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 SR 90 1.39E 10 1.64E 09 5.67E 10 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 ZR 95 1.1/E 01 5.46E 04 . 5.37E 01 1.72E 01 2.70E 01 0.00E-01 0.000-01 0.00E-01 1 131 1.43E 08 6.59E 07 1.74E 08 2.50E 08 4.28E 08 8.18E 10 0.00E-01 0.00E-01 1 133 1.26E 06 3.71E 06 2.37E 06 4.13E 06 7.21E 06 6.07E 08 0.00E-01 0.00E-01 CS134 1.72E 10 3.690 08 8.85E 09 2.11E 10 6.820 09 0.00E-01 2.26E 09 0.00E-01 CS136 1.06E 09 1.68E 08 3.75E 08 1.48E 09 8.23E 08 0.00E-01 1.130 08 0.000-01 CS137 1.10E 10 3.250 08 1.2SE 10 1.68E 10 5.70E 09 0.00E-01 1.89E 09 0.00E-01 UA140 1.01E 05 3.18E 06 1.54E 06 1.840 03 6.59E 02 0.00E-01 1.11E 03 0.00F-01 CE141 2.06E 01 6.940 05 2.68E 02 1.81E 02 8.43E 01 0.00E-01 0.00E-01 0.00E-01
- R values in units or mrem /yr por micro-Ci/m for inhalation and tritium, and in units of M2 -erem/yr por micro-Cl/sec for all others
. 1 Attact. RPAP-2E issue 1 Page 13 or 19 R VALUES FOR ISV*
PATilWAY = COATMILK ACE CROUP EQUALS TEEN NUCLIDE T.80DY Cl-1RACT BONE LIVER KIDNEY illVROI D LUNC SKIN 11 3 2 . 08:E 03 2 . 08:0 03 0.00E-01 2.OlsE 03 2.0fsE 03 2.0fsE 03 2. 08 E 03 2. 0fs f 03 CR 51 2.77C 03 4.66E 05 0.00E-01 0.00E-01 6.070 02 1.51sE 03 3.95E 03 0.000-01
- HN 54 1.71E 05 1.77E 06 0.00E-01 8.6fsE 05- 2.58E 05 0.00E-01 0.00E-01 0.00E-01 rE 59 2.A3E 05 1.7fsE 06 3.18E 05-4 7.384E 05 0.00E-01 0.00E-01 2.31E 05 0.00E-01 CO 58 1.084E 06 6.25E 06 0.00E-01 4.53E 05 0.00E-01 0.00E-01 0.00E-01 0.000-01
- CO 60 4.02E 06 2.32E 07 0.00E-01 1.78E 06 0.00E-01 0.00E-01 0.00E-01 0.00E-01 ZN 65 2.45E 08 2.22E 08 1.51E 08 5.25E 08 3.360 08 0.00E-01 0.00E-01 0.00E-01 SR 89 7.590 07 3.16E 08 2.65E 09 0.00E-01 0.00E-01 0.00E 0.00E-01 0.00E-01 SR 90 1.98E 10 2.25E 09 8.01E-10 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.000-01
- ZR 95 2. 08 E 01 6.84E 04 9.f l0E 01 2.97E 01 4.36E 01 0.00E-01 0.00E-01. 0.00E-01 i 131 2.38E 08 8.77E 07 3.17E 08 4.43E 08 7.63E 08 1.29E 11 0.00E-01 0.00E-01 1 133 2.2fsE 06 5.57E 06 4.3fst 06 7.36E 06 1.29E 07 1.03E 09 0.00E-01 0.00f-01 CS1384 1.68E 10 4.50E 08 1 . 58 E 10 3.62E 10 1.15E 10 0.00E-01 4.39E 09 0.000-01 CS136 1.69E 09 2.02E 08 6.38E 08 .2.51E 09 1.37E 09 0.00E-01 2.15E 08 0.00E-01 CS137 1.03E 10 4.21E 08 2.22E 10 2.96E 10 1.01E 10 0.00E-01 3.9tE 09 0.00E-01 Ball 0 1.80E 05 4.30E 06 2.79E 06 3.41E 03 1.16E 03 0.00E-01 2.30E 03 0.00E-01 CE141 3.77E 01 9.39E 05 4.92E 02 3.28E 02 1.55E 02 0.00E-01 0,00E-01 0.00E-01 lJ l
1
- R values in units or mrem /yr per micro-Cl/m for Inhalation and tritium, and in units or M2 -prem/yr por micro-Ci/sec for all others
e Attach. RPAP-PE Issue 1 Page 14 or 19 R VALUES FOR FSV*
PATifWAY = COATHILK AGE CROUP EQUALS CHILD NUCLIDE T. BODY Cl-TRACT BONE LIVER KlDNEY TilYROI D LUNO SKlH ll 3 3.230 03 3.23E 03 0.00E-01 3.23E 03 3.23E 03 3.230 03 3.23E 03 3.23E 03 CR 51 5.65E 03 3.00E 05 0.00E-01 0.00E-01 8.57E 02 3.14E 03 5.73E 03 0.000-01 MN 54 3.44E 05 1.08E 06 0.00E-01 1.29E 06 3.62E 05 0.00E-01 0.00E-01 0.000-01 FE 59 5.88E 05 1.23E 06 7.29E 05 1.18E 06 0.00E-01 0.00E-01 3.42E 05 0.000-01 CO 58 2.12E 06 4.040 06 0.00E-01 6.92E 05 0.00E-01 0.00E-01 0.00E-01 0.000-01 CO 60 8.17E 06 1.53E 07 0.00E-01 2.77E 06 0.00E-01 0.00E-01 0.00E-01 0.00E-01 ZN 65 4.92E 08 1.39E 08 2.97E 08 7.91E 08 4.98E 08 0.00E-01 0.00E-01 0.000-01 SR 89 1.87E 08 2.54E 08 6.56E 09 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 SR 90 3.43E 10 1.82E 09 1.350 11 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 ZR 95 4.27E 01 - 5.01E 04 2.18E 02 4.80E 01 6.87E 01 0.00E-01 0.00E-01 0.00f-01 1 131 4.39E 08 6.88E 07 7.68E 08 7.72E 08 1.27E 09 2.55E 11 0.00E-01 0.000-01 1 133 4.93E 06 5.25E 06 1.05E 07 1.30E 07 2.17E 07 2.42E 09 0.00E-01 0.000-01 CS134 1.23E 10 3.14E 08 3.55E 10 5.82E 10 1.800 10 0.00E-01 6.47E 09 0.00l-01 CS136 2.56E 09 1.39E 08 1.44E 09 3.96E 09 2.11E 09 0.00E-01 3.140 08 0.000-01 CS137 7.57E 09 3.21E 08 5.36E 10 5.13E 10 1.67E 10 0.00E-01 6.01E 09 0.00E-01 BA140 3.92E 05 3.4tE 06 6.72E 06 5.89E 03 1.92E 03 0.00E-01 3.510 03 0.00E-01 CE141 8.97E 01 7.54E 05 1.21E 03 6.04E O2 2.65E 02 0.00E-01 0.00E-01 0.000-01
- R valuts in units of mrom/yr por micro-Cl/m f'o r i nha l a t ion a nd t ri t i um, and in intits of M 2 -mrem /yr por micro-Ci/sec for all others
- ~_ , . ._ _ _ , _ _ . .. - _ _ - - _ _ _ - - _ - - _ _ - _
4 Attach. RPAP-2E issue 1 Page 15 or 19 R VALUES FOR FSV*
PAiliWAY = COAIMILK ACE CROUP EQUALS INEANT NUCL10E T.800Y GI-TRACT BONE LIVER KIONEY TilYRolo LUNG SKIN ll 3 4.90E 03 4.90E 03 0.00E-01 4.90E 03 4.90E 03 4.90E 03 4.90E 03 4.900 03 CR 51 8.95E 03 2.61E 05 0.00E-01 0.00E-01 1.280 03 5.84E 03 1.14E 04 0.00E-01 MN 54 5.45E 05 8.83E 05 0.00E-01 2.40E 06 5.35E 05 0.00E-01 0.00E-01 0.00I-01 FE 59 9.37E 05 1.14E 06 1.36E 06 2.38E 06 0.00E-01 0.00E-01 7.03E 05 0.00E-01 CO $8 3.45E 06 3.45E 06 0.00E-01 1.38E 06 0.00E-01 0.00E-01 0.00E-01 0.00E-01 CO 60 1.34E 07 1.350 07 0.00E-01 5.65E 06 0.00E-01 0.00E-01 0.00E-01 0.000-01 2N 65 6.31E 08 1.16E 09 3.99E 08 1.37E 09 6.63E 08 0.00E-01 0.00E-01 0.00E-01 SR 89 3.58E 08 2.57E 08 1.25E 10 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 SR 90 3.75E 10 1.84E 09 1.47E 11 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 ZR 95 6.70E 01 4.70E 04 3.88E 02 9.45E 01 1.02E 02 0.00E-01 0.00E-01 0.00E-01 1 131 8.31E 08 6.74E 07 1.60E 09 1.89E 09 2.21E 09 6.21E 11 0.00E-01 0.00E-01 1 133 9.49E 06 5.48E 06 2.23E 07 3.24E 07 3.81E 07 5.89E 09 0.00E-01 0.001-01 CS134 1.08E 10 2.89E 08 5.71E 10 1.07E 11 2.740 10 0.00E-01 1.12E 10 0.00E-01 i .
CS136 3.09E 09 1.26E 08 2.81E 09 8.27E 09 3.30E 09 0.00E-01 6.74E 08 0.000-01 CS137 7.10E 09 3.13E 08 8.55E 10 1.00E 11 2.69E 10 0.00E-01 1.090 10 0.00E-01 BA140 7.13E 05 3.40E 06 1.38E 07 1.38E 04 3.29E 03 0.00E-01 8.50E 03 0.00E-01 CE141 1.72E 02 7.57E 05 2.40E 05 1.46E 03 4.52E 02 0.00E-01 0.00E-01 0.00E-01 3
- R2 values in units of mrem /yr per micro-Cl/m for Inhalation and tritium, and in units or M Omrem/yr per micro-Ci/sec for all others
-_ _ _ _ _ ~
.s.
Attach. RPAP-20 1ssuo 1 Page 16 or 19 R. VALUES FOR FSV*
PATHWAY = INilAL ACE CROUP EQUALS ADULT NUCL10E T.800Y GI-TRACT BONE LIVER KIDNEY THYR 0lO LONG SKIN H 3 1.260 03 1.26E 03 0.00E-Ol 1.26E 03 1.26E 03 1.26E 03 1.26E 03 1.26E 03 CR 51 9.99E 01 3.32E 03 0.00E-01 0. 00 E-01 2.280 01 5.94E 01 1.44E 04 0.000-01 MN 54 6.29E 03 7.72E 04 0.00E-01 3.95E 04 9.83E 03 0.00E-01 1.40E 06 0.00E-01 IE 59 1.05E 04 1.88E 05 1.17E 04 2.77E 04 0.00E-01 0.00E-01 1.01E 06 0.00E-01 CO 58 2.07E 03 1.06E 05 0.00E-01 1.58E 03 0.00E-01 0.00E-01 9.27E 05 0.00E-01 CO 60 1.48E 04 2.84E 05 0.00E-01 1.15E 04 0.00E-01 0.00E-01 5.96E 06 0.00E-01 ZN 65 4.65E 04 5.34E 04 3.24E 04 1.03E 05 6.89E 04 0.00E-01 8.63E 05 0.000-01 SR 89 8.71E 03 3.49E 05 3.04E 05 0.000-01 0.00E-01 0.00E-01 1.40E 06 0.00E-01 SR 90. 6.09E 06 7.21E 05 9.91E 07 0.00E-01 0.00E-01 0.00E-01 9.59E 06 0.00E-01 ZR 95 2.32E 04 1.50E 05 . 1.07E 05 3.44E 04 5.41E 04 0.00E-01 1.710 06 0.00E-01 1 131 2.05E 04 6.27E 03 2.52E 04 3.57E 04 6.120 04 1.19E 07 0.00E-01 0.00E-01 1 133 4.51E 03 8.87E 03 8.63E 03 1.46E 04 2.58E 04 2.15E 06 0.00E-01 0.00E-01 CS134 7.27E 05 1.04E 04 3.72E 05 8.47E 05 2.87E 05 0.00E-01 9.75E 04 0.00E-01 CS136 1.10E 05 1.17E 04 3.90E 04 1.46E 05 8.55E 04 0.00E-01 1.20E 04 0.00E-01 CS137 4.27E 05 8.39E 03 4.78E 05 6.20E 05 2.22E 05 0.00E-01 7.51E 04 0.00E-01 BA140 2.56E 03 2.18E 05 3.90E 04 4.900 01 1.67E 01 0.00E-01 1.210 06 0.00E-01 CE141 1.53E 03 1.20E 05 1.99E 04 1.35E 04 6.25E 03 0.00E-01 3.61E 05 0.00E-01 3
- Ih values in units or urem/yr por micro-Cl/m for Inhalation and tritium, and in units of W '-ares /yr per micro-Ci/sec for all others
-i..
Attach. RPAP-20 issue 1 Page 17 of 19 l .
R VALUES FOR ISV*
PATHWAY = INHAL AGE CROUP EQUALS TEEN NUCL10E T.B00Y Cl-lRACT BONE LlVER KIDNEY THYROID LUNG SKIN 4
Il 3 1.27E 03 1.27E 03 0.00E-01 1.21E 03 1.210 03 1.27E 03 1.210 03 1.21f 53 CR 51 1.35E 02 3.00E 03 0.00E-01 0.00E-01 3.07E 01 7.49E 01 2.090 04 0.000-01 HN 54 8.39E 03 6.67E 04 0.00E-01 5.10E 04 1.2TE 04 0.00E-01 1.98E 06 0.00E-01 IE 59 1.43E 04 1.78E 05 1.59E 04 3.69E 04 0.00E-01 0.00E-01 1.530-06 0.00E-01 CO 58 2.77E 03 9.51E 04 0.00E-01 2.07E 03 0.00E-01 0.00E-01 1.34E 06 0.00E-01 CO 60 1.98E 04 2.59E 05 0.00E-01 1.51E 04 0.00E-01 0.00E-01 8.710 06 0.00E-01 ZN 65 6.23E 04 4.66E 04 3.85E 04 1.33E 05 8.63E 04 0.00E-01 1.24E 06 0.00E-01 SR 89 1.25E 04 3.71E 05 4.34E 05 0.00E-OI 0.00E-01 0.00E-01 2.410 06 0.00E-01 SR 90 6.67E 06 7.64E 05 1.08E 08 0.00E-01 .0.00E-01 0.00E-01 1.65E OT 0.00E-01 ZR 95 3.15E 04 1.49E 05 1.45E 05 4.58E 04 6.73E 04 0.00E-01 2.68E 06 0.00E-01 1 131 2.64E 04 6.48E 03 3.54E 04 4.90E 04 8.39E 04 1.46E 07 0.000-01 0.000-01 1 133 6.21E 03 1.03E 04 1.21E 04 2.0$E 04 3.59E 04 2.92E 06 0.00E-01 0.00E-01 CS134 5.48E 05 9.75E 03 5.02E 05 1.13E 06 3.75E 05 0.00E-01 1.46E 05 0.00E-01 CS136 1.37E 05 1.09E 04 5.14E 04 1.93E 05 1.10E 05 0.00E-01 1.77E 04 0.00E-01 CS137 3.11E 05 8.47E 03 6.69E 05 8.47E 05 3.04E 05 0.00E-01 1.21E 05 0.00I-01 J
4 BA140 3.51E 03 2.28E 05 5.46E 04 6.69E 01 2.280 01 0.00E-01 2.03E 06 0.000-01 CE141 2.16E 03 1.26E 05 2.84E 04 1.89E 04 8.87E 03 0.00E-01 6.130 05 0.00E-01 l
1 3
- R V11ues in units or mrem /yr por micro-Cl/m for inhalation and tritium, and in units or i h4 -erem/yr per micro-Ci/sec for all others
f P
A t t.a c h . HPAP-20 issue 1 Page 18 of 19 R VALUES FOR FSV*
PATHWAY = INHAL ACE CROUP EQUALS CHILD NUCLIDE T.B00Y GI-TRAC 1 BONE LIVER KIDNEY THYROID LUNG SKIN H 3 1.12E 03 1.12E 03 0.00E-01 1.12E 03 1.12E 03 1.120 03 1.12E 03 1.12E 03 CR 51 1.54E 02 1.08E 03 0.00E-01 0.00E-01 2.43E 01 8.53E 01 1.700 04 0.00E-01 MN 54 9.50E 03 2.29E 04 00.00E-01 4.29E 04 1.00E 04 0.00E-01 1.57E 06 0.00E-01 FE 59 1.67E 04 7.06E 04 2.07E 04 3.34E 04 0.00E-01 0.00E-01 1.21E 06 0.00E-01 CO $8 3.16E 03 3.43E 04 0.00E-01 1.77E 03 0.00E-01 0.00E-01 1.100 06 0.00E-01 CO 60 2.26E 04 9.61E 04 0.00E-01 1.31E 04 0.00E-01 0.00E-01 7.06E 06 0.00E-01 ZN 65 7.02E 04 1.63E 04 4.25E 04 1.13E 05 7.13E 04 0.00E-01 9.94E 05 0.00E-01 SR 89 1.72E 04 1.67E 05 5.99E 05 0.00E-01 0.00E-01 0.00E-01 2.15E 06 0.00E-01 SR 90 6.43E 06 3.43E 05 1.01E 08 0.00E-01 0.00E-01 0.00E-01 1.47E 07 0.00E-01 ZR 95 3.69E 04 6.10E 04 1.90E 05 4.17E 04 5.95E 04 0.00E-01 2.23S 06 0.00E-01 1 131 2.72E 04 2.84E 03 4.80E 04 4.80E 04 7.87E 04 1.62E 07 0.00E-01 0.00E-01 1 133 7.68E 03 5.47E 03 1.66E 04 2.03E 04 3.37E 04 3.84E 06 0.00E-01 0.000-01 CS134 2.24E 05 3.84E 03 6.50E 05 1.01E 06 3.30E 05 0.00E-01 1.21E 05 0.00E-01 CS136 1.16E 05 4.17E 03 6.50E 04 1.71E 05 9.53E 04 0.00E-01 1.45E 04 0.00E-01 CS137 1.28E 05 3.61E 03 9.05E 05 8.24E 05 2.82E 05 0.00E-01 1.04E 05 0.00I-01 BA140 4.32E 03 1.02E US 7.39E 04 6.47E 01 2.11E 01 0.00E-01 1.74E 06 0.00l.-01 CE141 2.89E 03 5.65E 04 3.92E 04 1.95E 04 8.53E 03 0.00E-01 5.43E 05 0.00r-01
- R values in units or arem/yr per micro-Cl/m for Inhalation and tritium, and in units of M2 -prem/yr per micro-Cl/sec for all others i
1 e
- Attach. RPA?-2E Issue 1 Page 19 or 19 R VALUES FOR FSV*
PATH 4AY = INilAL AGE CROUP EQUALS INFANT NUCLIDE T. BODY GI-TRACT BONE LIVER K10NEY THYRotD LUNG SKIN 11 3 6.460 02 6.46E 02 0.00L-01 6.46R O2 6.46E 02 6.46L 02 6.46L 02 6.461 02 CR 51 8.93E 01 3.56E 02 0.00E-01 0.00E-01 1.32E 01 5.75E 01 1.280 04 0.001-01 MN 54 4.98E 03 7.05E 03 0.00E-01 2.53E 04 4.98E 03 0.00E-01 9.98E 05 0.00E-01 FE 59 9.46E 03 2.47E 04 1.350 04 2.35E 04 0.00E-01 0.00E-01 1.01E 06 0.00E-01 CO 58 1.82E 03 1.11E 04 0.00E-01 1.22E 03 0.00E-01 0.00E-01 7.76E 05 0.00E-01 CO 60 1.18E 04 3.18E 04 0.00E-01 8.01E 03 0.00E-01 0.00E-01 4.50E 06 0.00E-01 ZN 65 3.10E 04 5.13E 04 1.93E 04 6.25E 04 3.24E 04 0.00E-01 6.46E 05 0.00E-01 SR 89 1.14E 04 6.39E 04 3.97E 05 0.00E-01 0.00E-01 0.00E-01 2.03E 06 0.00E-01 SR 90 2.59E 06 1.31E 05 4.080 07 0.00E-01 0.00E-01 0.00E-01 1.120 07 0.00E-01 ZR 95 2.03E 04 2.17E 04 1.15E 05 2.78E 04 3.10E 04 0.00E-01 1.75E 06 0.00E-01 1 131 1.96E 04 1.06E 03 3.79E 04 4.43E 04 5.1/E 04 1.48E 07 0.00E-01 0.00E-01 1 133 5.59E 03 2.15E 03 1.32E 04 1.92E 04 2.24E 04 3.55E 06 0.00E-01 0.00F-01 CS1384 7.44E 04 1.35E 03 3.96E 05 7.02E 05 1.90E 05 0.00E-01 7.95E 04 0.00E-01 CS136 5.280 04 1.43E 03 4.82E 04 1.34E 05 5.63E 04 ,
0.00E-01 1.17E 04 0.00E-01 CS137 4.54E 04 1.350 03 5.48E 05 6.11E 05 1.72E 05 0.00E-01 7.12E 04 0.00E-01 BA140 2.89E 03 3.83E 04 5.59E 04 5.59E 01 1.34E 01 0.00E-01 1.59E 06 0.00E-01 CE141 1.99E 03 2.15E 04 2.77E 04 1.66E 04 5.24E 03 0.00E-01 5.16E 05 0.000-01
- P values in units or mrem /yr per micro-Cl/m for Inhalation and tritium, and in units or h 2 arem/yr por micro-Cl/sec for all others
Attacle, itPAP-2F -
Issue 1 Page 1 of 8 RADIOLOGICAL ENVIRONMENTAL HONITORING PROGRAM SAMPLING SITE DFSCRIPTIONS fr: Facility Area 0-1.6_ km. At Adlacent_ Area 1.6-0 km. R: Referenco Arenj Exposure Pathway Site No. (Old Site No.) Location Description (see map) Sector Distanco, km Alrhorno F-16 F-1 Potato colla r 16 1.2 A-19 F-2 Ilunting cabin 1 1.1 F-7 F-3 Old da i ry shed 7 1.2 F-9 F-4 First shed along drive 8 1.5 A-20 Roor of PSC Orrice, 13 1/2 Main Strcot 10.5 Johnstown, CO R-3 Colorado State University Dairy W Drako 45.1 Road, Ft. Collins, CO R-4 Intersection of US 66 and US 28T 21.7 4
x E
D X C
Q
'C 6 m N **
- W M @
a = . . N. N. CO. N. m. a. A. N. O. c.
< CD C = - O O O. O - - - - - - O L
= 6 0
C N L UC C 4CC H &
Men mi o M awe O c O - N
<-b 6 w - N m : o C N c: m - - - -
c O
o :
L O n C ci 6 6 .C t t L 0 C C - C C a L C m .C8 Z L = > -
g O %
C 6 L
N N
th
.. C O C 6 N O V - ->
0 a o M C. U O C D 6 m 6 b E. G - C W C - C 4 E d O V - C =
0 g > c - 0 = Z 6 C 0 Z to O C C 4 O C C C 3 W e
- to o 6 d 0
-C tQ c:
O O Z c e
w w .Ca ec a 3 6 Ea
- -O eC >0 V -
o a O d e cc CL m C d C O LM
- = *
=
- C &
C W
e C
.C a a =o -6 0 W Q Z A e o A Z s o 6 m .L:
O - DD C 6 C C en a m a 6 CG Z =
c: C O <
d 6 O
- g C mC 6 .Oe C .o J
e ed J (4 - -E 0 Z OO O C = a C d - C Oe
< 6 M L C -
O6 -> c C
O
C - 6o O C U a=- 0 O - O k 6 6 -L Z" @ W & = a L f5 O 10 0 M co 0 WW D C == 0 -g g 3 m 6 e a cg Z p- cc O WG W a NC e 3 7 C Z C #
Z - -
Z Cr Z a L W X e 6 L O to 7 C Zo a = a L 0 = 3 e e -o c < o Eo E e . e 66 6 -o C
C o C = -
es o 2
E -C C C
ed aC
- 0 -
.a
> Z w 4o X - V a x a oe Z - *. m O 6 OW C O e c EO 6 .J < c m e* - - -
t- t 6 e* = d -
6 C
- C C C C C - 0 C J E . J -- O O L L A O N 6 C 6 A O
< < E o
to 1 O
O C.
J -
O 8 a.*
- O .
O O
< e5 Z K C L e
< .M.
o M
- 5 - N n
- D.- N : m m : - - -
- O e e e e e a e e O w 6 6 6 6 6 6 6 6 4
6 6 .
= C Z
C C e N M
& - N m n @ N cc m - - - -
= I I I 8 8 8 8 I B I I I I M 6 6 6 6 6 6 6 6 6 6 6 6 6 h C e o 2 -
a W
80 A T -
es 6
C &
W O O O a 6 X -
W O
+
m e k e
c n
F a P t
- s 5 8 2 2 5 4 4 5 4 2 / 3 7 6 8 2 P i . . .
A 8 D 1 1 1 0 P 8 8 7 7 7 6 7 4 4 7 7 P
R r o
.1 h 3 r ce o auo l t tsg a c tsa e e 4 5 6 3 0 0 1 AiP r S 1 1 1 1 1 1 2 3 4 5 6 / 8 9 1 1 A
e c
n y e r r 8 d e o E - 3 i 5 n e f d S r a 8 e c V e i e d d u S R s n ts n S n d I M g o nk a o U o o E A r n ic E '
t r d N R : o i e a N 9 r d9 p l n G R d l rr 2 e o a1 o ng O ) o l o ot n v o r r
oi R p N i p o f i E rr e s P m. a r u ER o r o l o e m ,e b ,
,R e d , r l r ld G h_ dn 2 l n m oE ie W oa N B e ar n r / ed o o r k Mn S po I S - e oo r o r 1 sn p .i a em r r R N 6 s rc a o ua t e 4 dk ,o o ,
O 0 ( b o t 1 o , c 9 n i 9c l 33 T t 1 rm d c 2 hy 0 e 2 0 s1 1 o 11 I i n oo f i a a 6 s 2 W p N P O I a
e i o r e ef r o s e d r n rw oh n r d e n 3
y
, S , dS p n n do nt M R r t n d r N a g o t a f r no an o ai C A p r io o f Si n o i oo o s L S i o sl n , o 6 h 6 i 4 a c 6 ; 6o A E t r c o r r 4 e lf 5
r 3 e d m rn 6o 2
/
6p p
I D n c Ep o o S 2 d l N e s t c t O oo o f i r ae Oo 1 Oo E E c e s nh n m C p r o s e fk Cp C M T a D e ot E r
e r n o
,o r S
r S l
c
,i r ,
6 fr
. N I
- l. 5 N C a fr l 2l O S d n a o f oe Di Se o e i 6h od o oe R A o e ld n r n Ct n l n n M 6c n no n I 3 i n oa o o y rr c mr o r o ra oh rr V N t po t e eo ,e ko p o s Of et c eo N I : a e r e i k nc ts c c o e Co ns r
os ncr E L A c l t l s r r n 6 t l l l P o o s o i u o e s W o i n o o o L M L P 1 P V T C D 1 i H P N o C P C A A m.
C S I
k G 6 O
L 1 O - )
I 0 .
D o A a N R e r e A t i
y S t n 0 i d 4 0 2 0 3 5 5 l l 1 1 3 3 5 3 3 3 i
O - - - - - - - -
c ( T T A A A A A A a
r r .
( o N
e 4 5 6 7 8 0 1 t 1 1 1 1 1 1 2 3 4 5 6 7 8 9 1 1 i - - - - - - - - - - - - - - - -
S F T F T 0 A A A A A A A A A A A y n a
w io h t t a a i P d a
e R r
u t
s c o e p r x i E D l
i ',
. m .
k e
c n
f a 3 2 t 8 1
- s 2 8 9 7 8 3 3 9 .
P i . 0 5 9 A 8 D 7 5 6 6 6 9 9 5 1 4 1 P -
R r _
o _
.1 h 4 r ce o _
ate e j t tsg a c tsa e e 2 3 4 S 6 AIP r S 1 1 1 I 1 A
e c
n e
r o -
e , W l t n e f N s S o u o k 7 e e r r p o a 8 R ) t e e n e r 2 M 8 i n n o , t l D
A 9 p r r m s o S R : 9 o o e u u p WU G R 4 e c c l i J
O ) ( g r o ry , n f R
P
. p a e a W N N W en p ot r tr e
)
y o o m l k m s i r , ie n r m r e r -
u s dp r a -
G , , o 2 N 8_ e o 0 5 c / uo o t a nr I S - e h r 4 1 1 arp c n f R N s o W t e o O O G. ( e d d S 1 o l W m y c T I 1 t N n n 2l ol N e r I T n i a a , oo l i n N
O P
I a
e i o h w e 3 2 9
1 nl oo ch ho l r
,d
(
e d a io M R r t s kd 1 4 o Sc oa e t C A p ra aa d l,h s oy l v , a L S i om l o f f n c t h oi r c A E t r o r o o a os sf cl or e o T D n c Eh e o eo So hd r
l p
l N e s T tr n n 4 hf o c 6 e e io i o 4r Sco cdn leh Sr E E M T c
a D l e sio l c o am s r6e
. N I
- l. ok oe t t r ie i s n lpC O O S d n pa pd c c o ne G l wd R A o pi
,L os s s e e en S ve on r m I
G i r kr d ed te i ad V N t 4r r r e io nn ti s a sn N : a 3o eE e e n l ts nS a E
I L A c l t t r l c hio a h U ir P o n o n n o i e l o S L M . L O P I I C M B P J C A A A m C S k I
G 6 O
L 1 O - )
I 0 .
D o A a N R e r e A i t
y S t
i d l l i O c (
a F
r .
f o N
e 2 3 4 5 6 1
7 1
8 1 2 3 4 t 1 1 1 1 1 i - - - - - - - - - - -
S A A A A A R A A R R R y n a i o
w h t t a a i P d a
e R r
u t s c o .
e p r x i E D
Attach. RPAP-2F lssue 1 Pago 5 of 8 RADIOLOGICAL ENVIRONMENTAL HONITORING PROGRAM SAMPLING S11E DESCRIPI'lONS (F: Faci l i ty Area 0-1.6 km. A: Ad_lacent Area 1.6-8 km. R: Rorerence Arca]
- Exposure Pativway Site No. (Old Site No.) Location Description (see map) Sector Distance, km Waterborno Surface F-19 U-43 S Platte at dam and inlet pond 4 1.2 A-21 U-42 St. Vrain Creek at bridge on 34 11 2.4 A-22 D-40 S Platte at CO 60 2 10.1 4
F-20 D-45 St. Vrain Creek on 19 1/2, 0.3 km 16 1.5 f rom discha rge A-25 E-38 Goosequill Pond outlet i 2.2 Ground A-19 r-2 Well supply to hunting cabin i 1.T R-5 Milliken City well, behind Town Ita ll 9.8 Drinking R-3 CSU dai ry W Drake Road, ft. Collins, CO 4 '> .1 R-6 D-39 Gilcrest City water, US Post Offico 9.3 4
4
- y. - - . u - e -w t
Attach. RPAP-2F issue 1 Page 6 or 8 RADIOLOGICAL ENVIRONMENTAL MONITORING PROCRAM SAMPLING SITE DESCRIPIIONS ff: Facility Area 0-1.6 km. A: Ad lacent Area 1.6-8 km. R: Reference Area)
Exposure Pathway Site No. (Old Site No.) location Description ( sco map) Sector Distanco, km Fa te rbo rDe Sediment from A-22 D-40 S Platto at CO 60 2 10.0 Shoreline Ingestion Milk A-23 F-44 Leroy Odenbaugh dai ry . 5 2.9 A-24 A-6 C. Wissler dai ry 4.0 km S of 8 8.8 Plattevillo A-6 A-50 liendrickson dai ry on 32, 1.3 km E or 6 6.6 Platteville R-7 A-48 Bill Ray da i ry, 17376 Wold County Road 3 9.6 46, 0.8 km L of US 85 on 46 R-8 R-16 Mountain View Farms N side or CO 402 22.5 W or 1-25 R-9 R-22 llagan Brothers Dairy, 6.8 km S or 11.9 Platteville R-3 CSU da i ry, W Drako Road, Fort Collins. 4r,, g CO Aquatic Blota A-25 E-38 Goosequill Pond outlet i 2.2 F-19 U-43 S Platte at dam and inlet pond 4 1.1 A D-40 S Platte at CO 60 2 10.1
t A t tacle. HPAP-2r issue 1 Page 7 or 8 RADIOLOGICAL ENVIRONMENTAL HONITORING PROGRAM SAMPLING SITE DESCRIPTIONS (F: Facility Area 0-1.6 km. A: Ad_lacent Area 1 6-g_km. R: Reference Area)
Exposure Pathway Site No. (Old Site No.) Location Description (sco ap) Sec to r Distance, km Food Products F-21 Fa rm. N or F-1 1 1.5 r-22 Fa rm at F-14, rields S and E 15 0.8 23 16 1.5 T-24 Farm plots 2 0.9 25 to 0.9 26 II 0.8 R-9 R-22 llagan Brothers Dai ry, 6.8 km S or 6.8 Platteville
PUBLIC SERVICE COMPANY OF COLOR ADO' Attach. RPAP-2F l FORT ST. VRAfN NUCLEAR GENERATING STATION ssue 1 Page 8 of 8 f
RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM SAMPLING SITE DESCRIPTIONS
~
.h.[.-[.
? . RPAP.2F
.c # _ p ', , w x L ,,,,,hj , , ,
/.Y '.. h-)
(V k .h0;$
,' ? 0 ( Y ~ $ b , L 'I fV.
dysQ
=
BM a, ,.... /. w .. a.
) f. 5 .
h %.
c h w k . ,
? N. ,-.n-.r. 3 $
% ..~. 5 f NI s
, -.b, l - nW ,
, ~, ./
S ilW.EAii
' ~
'.h h ;&;:%,Sl..'Is.-- ,w[ ,' '
le .:'
.WG j L JA i(
A6
&, fKo - . . . [%K,. y.:.W*V,. . i.V< ,
.. - A '/. / .
d M& %.
e .,g. N A .f.h s
Sa? v. .. - f.>&.%
R>k@.M raj, .n isQ . m? % ws Q -i.~ . >$ J. f>== <e m . #$yTB C T2 j- -
,l, 1. 'jWM M Nc.'VJ^L-4'[ff N O3
' ?n(. ~ ...*:$x..
) fh .}+f,.c. xw. k ' c;hw-m .
bhklh.
$ $k 5 '~h?"f Y.? .f..#$i ::^/lc
' 2f.am4 1 g: Nyd .A 6 QA _
A_ MMS mA $@ ad 6 3 _%B7 $ $ . .
~
e c'
..j.
rA wm.Amxe
~
e m
ww.m.
- KQN! '7 d
'o uhm1WM% .'
- m. ' , , , , , , ' ,
4 ;'5. k 'l !J\ l l ' N 3 5 k FORM 372 22 3643
-